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INTRODUCTION: The high physical and economic burden of type 2 diabetes mellitus is an 
important public health concern. The impact of various intensities of physical activity (PA) and 
sedentary behavior on the development of type 2 diabetes is not well understood. Additionally, 
more insight into how measurement methodologies for PA and sedentary behavior affect the 
values of activity-related outcome variables is needed. 
 
METHODS: PA and sedentary behavior levels were assessed as p art of a multi-center clinic 
trial of youth with type 2 di abetes from 15 U.S. centers; the Treatment Options for type 2 
Diabetes in Adolescents and Youth (TODAY) study.  A greement between the results of a 
subjective and objective measure of PA and sedentary behavior were examined.  Also, 
accelerometer processing algorithms were examined, using data on adults in the National Health 
Examination and Nutrition Survey (NHANES) 2005-06, to determine how changing the 
definition of accelerometer non-wear impacts on important PA outcome variables. PA and 
sedentary behavior levels from accelerometers were also described in 1609 adults with impaired 
glucose tolerance or type 2 diabetes, in the multi-center Diabetes Prevention Program Outcomes 
Study (DPPOS). These results were compared to similarly assessed activity data for a nationally 
representative sample of adults.  
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RESULTS: In TODAY youth, agreement was low between the Three Day Physical Activity 
Recall (3DPAR) questionnaire and accelerometer results; suggesting that the 3DPAR may not 
provide an accurate measure of time spent in PA or sedentary behavior in overweight/obese 
youth with type 2 diabetes. For NHANES adults, changing the definition of accelerometer non-
wear time resulted in clinically significant differences in estimates of time spent sedentary, 
especially in older individuals.  Compared to a nationally representative sample of adults, the 
DPPOS participants performed more moderate-vigorous intensity (MV) PA, but not more light 
intensity PA. These results likely reflect the effects of a successful lifestyle intervention on 
MVPA. 
 
PUBLIC HEALTH SIGNIFICANCE: The current effort advances the understanding of PA 
and sedentary behavior assessment methods in populations with impaired glucose tolerance and 
type 2 di abetes and provides estimates for the average amount of time individuals in these 
populations spend physically active and sedentary. 
 
 
vi 
TABLE OF CONTENTS 
1.0 INTRODUCTION ........................................................................................................ 1
1.1 DIABETES RISK AND PHYSICAL ACTIVITY ............................................ 1
1.2 MEASURING ACTIVITY ................................................................................. 5
1.3 STUDY GOALS ................................................................................................... 7
2.0 GLUCOSE METABOLISM & TYPE 2 DIABETES ............................................. 12
2.1 OVERVIEW OF GLUCOSE METABOLISM ............................................... 12
2.2 INSULIN RESISTANCE .................................................................................. 14
2.3 TYPE 2 DIABETES MELLITUS .................................................................... 15
3.0 MEASUREMENT OF PHYSICAL ACTIVITY AND SEDENTARY 
BEHAVIOR IN EPIDEMIOLOGICAL STUDIES ................................................................. 19
3.1 SUBJECTIVE MEASURES- SELF-REPORT ............................................... 21
3.2 OBJECTIVE MEASURES- ACCELEROMETRY ....................................... 28
3.3 PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOR ASSESSMENT 
IN CHILD AND ADOLESCENT POPULATIONS ....................................................... 32
3.4 PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOR ASSESSMENT 
IN POPULATIONS WITH DIABETES .......................................................................... 35
4.0 TYPE 2 DIABETES MELLITUS, PHYSICAL ACTIVITY, AND SEDENTARY 
BEHAVIOR ................................................................................................................................. 38
vii 
4.1 BIOLOGICAL CONNECTION ....................................................................... 38
4.2 PHYSICAL ACTIVITY, SEDENTARY BEHAVIOR,  AN D TYPE 2 
DIABETES MELLITUS .................................................................................................... 39
4.3 PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOR LEVELS IN 
INDIVIDUALS WITH TYPE 2 DIABETES ................................................................... 42
5.0 PAPER #1: ASSESSMENT OF PHYSICAL ACTIVITY AND SEDENTARY 
BEHAVIOR IN YOUTH WITH TYPE 2 DIABETES ........................................................... 45
5.1 BRIEF OVERVIEW OF TODAY TRIAL ...................................................... 45
5.1.1 Measures ......................................................................................................... 47
5.1.1.1 Demographics ...................................................................................... 47
5.1.1.2 Physical Activity- Subjective .............................................................. 47
5.1.1.3 Physical Activity- Objective ............................................................... 48
5.1.1.4 Anthropometrics ................................................................................. 49
5.1.2 Baseline Demographic and Anthropometric Characteristics .................... 49
5.2 PAPER #1 OVERVIEW ................................................................................... 50
6.0 PAPER #2: DIFFERENCES IN PHYSICAL ACTIVITY OUTCOMES DUE TO 
ACCELEROMETER NON-WEAR ALGORITHMS ............................................................ 52
6.1 BRIEF OVERVIEW OF NHANES ................................................................. 52
6.1.1 Measures ......................................................................................................... 54
6.1.1.1 Demographics ...................................................................................... 54
6.1.1.2 Physical Activity .................................................................................. 54
6.1.1.3 Laboratory Data .................................................................................. 56
6.1.1.4 Anthropometrics ................................................................................. 56
6.2 OVERVIEW PAPER #2 ................................................................................... 57
viii 
7.0 PAPER #3: PHYSICAL ACTIVITY & SEDENTARY BEHAVIOR IN THE
DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS) ........................ 59
7.1 DPP AND DPPOS FOLLOW-UP STUDIES .................................................. 59
7.2 MEASUREMENTS IN THE DPPOS .............................................................. 63
7.2.1 Demographics................................................................................................. 63
7.2.2 Physical Activity ............................................................................................ 63
7.2.3 Laboratory Measures .................................................................................... 63
7.2.4 Anthropometrics ............................................................................................ 64
7.3 DPPOS ACCELEROMETER ANCILLARY STUDY .................................. 65
7.3.1 Study Objectives ............................................................................................ 66
7.3.2 Physical Activity Data Collection and Processing ...................................... 67
7.3.3 Eligibility and Recruitment .......................................................................... 69
7.3.4 Enrollment and Retention ............................................................................ 69
7.3.5 Participant Characteristics ........................................................................... 71
7.4 PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOR LEVELS IN 
THE DPPOS COHORT ..................................................................................................... 72
7.4.1 Statistical analyses ......................................................................................... 72
7.4.2 Unadjusted estimates of physical activity and sedentary behavior .......... 72
7.4.3 Identification of important covariates for physical activity and sedentary 
behavior levels in the DPPOS ................................................................................... 73
7.4.4 Adjusted least square means for time spent in physical activity and 
sedentary behavior among DPPOS participants ..................................................... 74
7.4.5 Summary ........................................................................................................ 79
ix 
7.5 NHANES 2003-06 COMPARISON POPULATION ...................................... 80
7.5.1 Statistical analyses for NHANES descriptive statistics .............................. 80
7.5.2 NHANES participant characteristics........................................................... 82
7.5.3 Comparison of diabetes status classification between the oral glucose 
tolerance test and fasting plasma glucose ................................................................ 85
7.5.3 Physical activity and sedentary behavior levels for individuals in the 
fasting subsample and for individuals in the OGTT subsample ........................... 87
7.5.4 Summary ........................................................................................................ 90
7.6 COMPARISON OF PHYSICAL ACTIVITY AND SEDENTARY 
BEHAVIOUR BETWEEN DPPOS AND NHANES PARTICIPANTS ........................ 91
7.6.1 Statistical analyses ......................................................................................... 92
7.6.2 Descriptive comparisons of DPPOS and NHANES physical activity and 
sedentary behavior levels stratified by age and gender .......................................... 93
7.6.3 Descriptive comparisons of DPPOS and NHANES physical activity and 
sedentary behavior levels stratified by age, gender, and diabetes status .............. 95
7.6.3.1 Comparisons for different intensities of physical activity ............... 96
7.6.3.2 Comparisons for sedentary behavior .............................................. 100
7.6.3.3 Ogtt subsample comparisons ........................................................... 103
7.6.3.4 Summary ............................................................................................ 107
7.6.4 Discussion ..................................................................................................... 108
8.0 DISSERTATION FINAL ASSESSMENT ............................................................. 111
8.1 OVERALL CONCLUSIONS ......................................................................... 111
8.2 PUBLIC HEALTH SIGNIFICANCE ............................................................ 113
x 
8.3 FUTURE DIRECTIONS ................................................................................. 114
APPENDIX A : MEAN VALUES FOR PHYSICAL ACTIVITY AND SEDENTARY 
BEHAVIOR RELATED VARIABLES BY AGE, GENDER, AND DIABETES 
STATUS..................................................................................................................................... 116
APPENDIX B: LIST OF ABBREVIATIONS........................................................................ 119
BIBLIOGRAPHY ..................................................................................................................... 122
xi 
LIST OF TABLES 
 Table 2.1 Criteria for the diagnosis of diabetes mellitus (ADA Criteria) .................................... 15
Table 3.1 Activity Intensity Categories for Adults, Children and Adolescents ............................ 20
Table 7.1 Basic demographic variables and randomized arm assignment for all individuals 
enrolled in the DPPOS accelerometer study and for those individuals with at least 4 valid days of 
recorded wear time. ....................................................................................................................... 71
Table 7.2 Unadjusted descriptive statistics for activity-related variables for the 1609 DPPOS 
participants with at least 4 valid days of wear time. ..................................................................... 73
Table 7.3 Adjusted least-square means (95% CI) by treatment group for time (minutes/day) spent 
in different intensities of physical activity and sedentary behavior. ............................................. 75
Table 7.4 Adjusted least-square means (95% CI) by ge nder for time (minutes/day) spent in 
different intensities of physical activity and sedentary behavior.  ................................................ 76
Table 7.5 Adjusted least-square means (95% CI) by age group for time (minutes/day) spent in 
different intensities of physical activity and sedentary behavior. ................................................. 77
Table 7.6 Adjusted least-square means (95% CI) by race/ethnicity for time (minutes/day) spent 
in different intensities of physical activity and sedentary behavior. ............................................. 78
Table 7.7 Population weighted demographic data for participants  age ≥40 years, with 4+ valid 
days of accelerometer data from NHANES 2003-06. .................................................................. 83
 xii 
Table 7.8 Sensitivity, specificity, PPV, and NPV for the identification of impaired glucose 
tolerance and type 2 di abetes mellitus, by f asting plasma glucose (FPG); when compared to 
results from the oral glucose tolerance test (OGTT). ................................................................... 86 
Table 7.9 Descriptive statistics based on population weighted estimates of activity-related 
variables for individuals aged ≥40 years in the NHANES 2003-06 fasting sample group.  ........ 88 
Table 7.10 Descriptive statistics based on population weighted estimates of activity-related 
variables for individuals aged ≥40 years in the NHANES 2005-06 OGTT sub-sample. ............. 89 
Table 7.11 Mean values for sedentary behavior and physical activity-related variables for female 
participants from the DPPOS and the NHANES 2003-06 fasting subsample (≥40 years of age) by 
age group ....................................................................................................................................... 94 
Table 7.12 Mean values for sedentary behavior and physical activity-related variables for male 
participants from the DPPOS and the NHANES 2003-06 fasting subsample (≥40 years of age) by 
age group ....................................................................................................................................... 95 
Table A.1 Mean values for sedentary behavior, different intensities of physical activity, and 
wear time for male participants from the DPPOS, the NHANES 2003-06 fasting subsample,
and the NHANES 2005-06 OGTT subsample (≥40 years of age). .......................................... 117 
Table A.2 Mean values for sedentary behavior, different intensities of physical activity, and 
wear time for female participants from the DPPOS, the NHANES 2003-06 fasting subsample,
 and the NHANES 2005-06 OGTT subsample (≥40 years of age). ........................................... 118 
Table B.1 The following table lists various abbreviations and acronyms used throughout the 
dissertation. The page on which each one is first used is also given. ......................................... 120
 
 xiii 
LIST OF FIGURES 
Figure 3.1 Freedson cut-points for accelerometry & th e corresponding MET-based physical 
activity intensities ......................................................................................................................... 30 
Figure 7.1 Timeline & enrollment figures for the original DPP, the DPPOS follow-up study, & 
the DPPOS Accelerometer Ancillary Study ................................................................................. 62 
Figure 7.2 Enrollment and retention of DPPOS Accelerometer ancillary study participants ...... 70
 
Figure 7.3 Mean minutes/day spent in moderate-vigorous activity by gender and age group for 
adults age ≥ 39 years (≥40 years for NHANES) with ≥ 4 valid days of monitoring. ........ 97
 
Figure 7.4 Mean minutes/day spent in light intensity physical activity by gender and age group 
for adults age ≥ 39 years (≥40 years for NHANES) with ≥ 4 valid days of monitoring. ....... 99
Figure 7.5 Mean minutes/day spent in sedentary behaviors by gender and age group for adults 
age ≥ 39 years (≥40 years for NHANES) with ≥ 4 valid days of monitoring. .......... 102
Figure 7.6 Mean minutes/day spent in moderate-vigorous activity by gender and age group for 
adults age ≥ 39 years (≥40 years for NHANES) with ≥ 4 valid days of monitoring ....... 104
Figure 7.7 Mean minutes/day spent in light intensity physical activity  by gender and age group 
for adults age ≥ 39 years (≥40 years for NHANES) with ≥ 4 valid days of monitoring. .......105
 xiv 
Figure 7.8 Mean minutes/day spent in sedentary behaviors by gender and age group for adults 
age ≥ 39 years (≥40 years for NHANES) with ≥ 4 valid days of monitoring. ........................... 106
 xv 
PREFACE 
AKNOWLEDGEMENTS 
 
“We plan our lives according to a dream that came to 
us in our childhood, and we find that life alters our plans. 
And yet, at the end, from a rare height, we also see that our 
dream was our fate. It's just that providence had other ideas 
as to how we would get there. Destiny plans a different 
route, or turns the dream around, as if it were a riddle, and 
fulfills the dream in ways we couldn't have expected.” 
- Ben Okri 
 
Earning my PhD was always my childhood dream. I am eternally grateful that the route 
was at times more challenging and definitely more remarkable than the “expected” route would 
have been.  
I would like to thank my family for their constant support and unwavering faith. 
I would also like to thank my advisor, Dr. Andrea Kriska, and my committee members 
for their encouragement and guidance. 
 
 
 
 1 
1.0  INTRODUCTION 
1.1 DIABETES RISK AND PHYSICAL ACTIVITY 
Diabetes is the most common disease involving impairment of glucose metabolism. Type 
2 diabetes is a sub-classification of diabetes that typically results from insulin resistance and/or β 
cell dysfunction and is characterized by poor  glucose regulation that often does not require 
insulin therapy.1 Levels of blood glucose diagnostic of diabetes are 126 mg/dl or greater after 
fasting at least 8 hour s and 200 mg/dl or greater 2 hour s after a 75 g ram glucose solution is 
administered (post-load test).  A common precursor of type 2 di abetes, impaired glucose 
tolerance, is a chronic state of glucose metabolism dysfunction marked by blood glucose levels 
that are above normal, but lower than those diagnostic of type 2 diabetes.2  
Currently, the World Health Organization (WHO) estimates that 90% of the 346 million 
diabetic individuals worldwide have type 2 di abetes.3 This represents an increase in the 
prevalence of type 2 diabetes of over 50% during the past seventeen years.4,5 It is projected that 
as many as 380 million people around the globe will have type 2 diabetes by 2025 a nd another 
418 million people will have impaired glucose tolerance.6,7 In 2010 about 8.3% of adults in the 
United States had diabetes, but the prevalence rate is expected to more than triple by 2050 .8 
Rates among children and adolescents (< 20 years of age) in the United States are expected to 
increase by 178 percent by 2050 (from .27 per 1,000 to .75 per 1,000).9 
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The most common complications of diabetes include macrovasular complications related 
to cardiovascular disease (CVD), such as angina, myocardial infarction, stroke, peripheral artery 
disease, and congestive heart failure.7  CVD is the leading cause of death among patients with 
type 2 diabetes and accounts for nearly 50% of all deaths among individuals with diabetes. Other 
common complications of diabetes are blindness, renal failure, and lower limb amputations;7,10 
all of which are caused by microvascular complications that include nephropathy, retinopathy, 
neuropathy, and small vessel vasculopathy. It has been suggested that individuals with diabetes 
are 1.80 (95% CI 1.71, 1.90) times more likely to die of any cause and 2.32 (95% CI 2.11, 2.56) 
times more likely to die of vascular causes when compared to individuals without diabetes.11  
Additionally, the economic costs of diabetes in the United States increased over 75% between 
1997 and 2007 and in 2010 cost projections indicate that 12% of all global health expenditures 
were put toward diabetes.12-14 The cost of treating diabetes, worldwide, is expected to increase 
over the coming decades, as the number of diagnosed cases increases. 
The development of type 2 di abetes usually takes place over a period of years and is 
thought to be the product of a combination of personal risk factors that involve both inherited 
susceptibility and environmental/lifestyle related factors. The primary risk factors for the 
development of type 2 diabetes include impaired glucose tolerance, physical inactivity, 
overweight/obesity, older age, race/ethnicity and genetics, and previous gestational diabetes.15 
Some risk factors for type 2 diabetes, such as age, race/ethnicity, and genetics, are unavoidable. 
However, other risk factors such as o verweight/obesity and physical inactivity are modifiable 
and can therefore be targeted in prevention and intervention efforts to reduce the risk of 
developing diabetes, slow down the disease progression, and/or reduce risk for complications in 
patients with diabetes.15 
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Overweight/obesity and physical inactivity are often referred to as lifestyle factors 
because they often result from personal choices related to diet and participation in activities that 
require lower energy expenditure. The results of several clinical trials aimed at reducing or 
delaying incident type 2 diabetes showed that lifestyle changes involving improvements in diet 
and physical activity were able to significantly improve measures of body c omposition and 
decrease incidence of type 2 diabetes in high risk individuals.16-19 In particular the results of the 
Diabetes Prevention Program (DPP) showed that incident diabetes was reduced by 58% in the 
lifestyle intervention group compared to placebo, over an average follow-up of 3.2 years in 
adults that were at high risk for developing the disease. 16 Additionally, lifestyle interventions 
have been shown to improve control of blood glucose levels in people with type 2 diabetes and 
reduce the incidence of complications.20-22 
Most lifestyle interventions for type 2 di abetes incorporate dietary modification with 
increases in moderate-vigorous intensity physical activity that are aimed at reducing measures of 
body composition.23,24 Currently, there is evidence that increasing physical activity is related to 
reductions in diabetes development both through weight loss25 and independent of weight 
loss.26,27 First, there is biological evidence that physical activity can improve insulin uptake, even 
when there is a d ysfunction in the signaling pathway related to insulin induced uptake.28-31  
Additionally, prolonged periods of inactivity may influence diabetes development by a ffecting 
the body’s ability to regulate the enzyme, lipoprotein lipase, which is involved in the hydrolysis 
of triglycerides.32,33 Also, inactivity may affect diabetes development through involvement in the 
regulation of β cell function.34-37 
Supporting this, is evidence from clinical trials and epidemiologic studies for an 
independent effect of physical activity on diabetes development. More specifically, analysis from 
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the DPP showed that individuals who reported meeting their exercise goal (150 minutes/week of 
moderate-vigorous activity) at year one, but did not report meeting their weight loss or fat goals 
at year one still had a 46% reduction in risk of developing diabetes during the remainder of the 
3.2 year follow-up when compared to individuals who reported meeting none of the goals.38 
Also, the Da Qing clinical trial tested the individual effects of diet and exercise by creating 
separate intervention arms for exercise and dietary modification. The results showed that over a 
six year follow-up in individuals at high risk for the disease, there was a 46% risk reduction for 
diabetes in the exercise group when compared to the placebo group.26  Finally, an analysis of 
eight previously published longitudinal studies concluded that there was evidence for a joint 
effect and for independent effects of both obesity and inactivity on incident type 2 di abetes.39 
Therefore, the results indicated that improvements to physical activity could reduce the risk 
associated with activity alone, as well as, some of the joint risk associated with both inactivity 
and obesity. 
So far, much of the focus on the relationship between physical activity and diabetes has 
focused on moderate to vigorous intensity physical activities, such as brisk walking or jogging. 
However, in addition to the effects of moderate and vigorous activity, there is growing evidence 
that increasing light intensity activity, such as slow walking or light housework, and reducing 
sedentary behavior, such as sitting watching television, may exert an added benefit toward 
diabetes prevention. 40-44 In relation to this, the results of several studies have suggested that 
there is an effect of sedentary behavior on outcomes related to type 2 diabetes that is independent 
of the effects of moderate-vigorous activity.45-48 For example, a study of accelerometer data from 
NHANES 2003-06 reported that, in adults, the amount of time spent sedentary (controlling for 
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time spent in moderate-vigorous activity) was positively associated with diabetes related 
outcomes including insulin, and markers of β cell function and insulin sensitivity.48  
It is also important to consider the fact that based on current health surveys, adults in the 
United States and elsewhere, spend about two-thirds of their waking hours in sedentary 
pursuits.49,50  Accelerometer data collected on youth in the United States and Europe indicate that 
youth aged 6-11, 12-15 and 16-19 years spent about 6.44, 7.39, and 7.89 hours/day (on average) 
in sedentary pursuits, respectively.51  Furthermore, reports of physical activity and sedentary 
behavior levels in the United States and Worldwide indicate that, in general, current populations 
are spending more of their time performing activities that require lower levels of energy 
expenditure than people did in the past. 52-54 As a result, there is an increasing need to consider 
the effects of activities from all parts of the physical activity spectrum (from light to vigorous 
intensity) on impaired glucose tolerance and type 2 diabetes.  
1.2  MEASURING ACTIVITY 
Most evidence regarding the effect of activity/inactivity on diabetes development has 
been collected using subjective questionnaires. This type of assessment is popular due to design 
flexibility and low participant/ investigator burden.55,56 Furthermore, many questionnaires have 
been shown to be valid and reliable measures of habitual moderate-vigorous intensity physical 
activity and specific domains of sedentary behaviors, such as si tting watching television.57,58  
However, self-report has been shown to be less valid and reliable for measuring unplanned 
activities, light intensity activities, and total sedentary behavior.55,57  Most questionnaires do not 
or cannot attempt to collect this information.  
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Compared to subjective measures, an objective measure of physical activity and 
sedentary behavior, the accelerometer, has been shown to be more accurate and reliable for 
determining all levels of total physical activity (which includes light, moderate, and vigorous 
activity) and sedentary behavior. More specifically, accelerometers are generally better at 
capturing unplanned activities and can provide a more accurate picture of behaviors that occur at 
the lower intensity end of the physical activity spectrum.59 Also, objective measures are less 
influenced by bias because they are not subject to personal opinions and perceptions, or other 
types of reporting bias that can affect the results of subjective measures.60 Therefore, a major 
advantage of accelerometry, is the ability to capture physical activity that takes place across the 
spectrum of intensity levels. 
Originally, accelerometer derived physical activity data processing was focused on the 
reporting of moderate-vigorous intensity physical activity. Many of the methods currently used 
to process accelerometer data were developed and validated for the assessment of moderate-
vigorous physical activity, specifically. Now that the research focus has expanded to include 
lower intensity activities, not all methods used in the processing and interpretation of physical 
activity from accelerometers have been shown to be equally valid for reporting sedentary 
behavior. 61-69  Some examples of this are monitor calibration and recording, identification of 
wear time, and number of days required to report “typical” behavior. Therefore, indicating that 
as we move forward with physical activity assessment that includes sedentary behavior, there is a 
need to reassess aspects of data processing, such as t he determination of wear time, that have 
been previously validated for reporting physical activity, but not sedentary behavior.  
To conclude, although type 2 d iabetes rates are rising at an alarming pace in both the 
United States and World Wide, it is a highly preventable disease. The modification of lifestyle 
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related factors including inactivity and obesity have been shown to greatly reduce the incidence 
of type 2 diabetes in a wide diversity of populations and to improve health outcomes for people 
with diagnosed diabetes. However, based on our current understanding of the importance of all 
intensities of activity to diabetes related outcomes, there is a need for capturing all components 
of activity, as well as, sedentary behavior. Therefore, additional studies are still needed to 
determine the levels of physical activity and sedentary behavior in populations with diabetes 
and/or impaired glucose tolerance and to determine if there are differences in activity and 
sedentary behavior between individuals with and without impaired glucose metabolism. As part 
of this effort, it will also be important to assure that measurement methods previously validated 
for physical activity are also shown to be accurate and reliable for measuring sedentary 
behaviors.   
1.3 STUDY GOALS 
The purpose of this effort is to characterize physical activity and sedentary behavior 
levels across a diverse range of individuals with type 2 diabetes and/or impaired glucose 
tolerance and to examine some of the aspects of measuring physical activity and sedentary 
behavior that could affect the values of activity-related outcome variables in the study 
populations. More specifically, this study will meet the following objectives: 
1. Report physical activity and sedentary behavior levels in youth with type 2 diabetes using 
both a subjective and objective measure and determine the level of agreement between 
the results of the two measurement instruments, for this population. 
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Manuscript 1 will present estimates of baseline physical activity and sedentary behavior 
levels for youth aged 10-18 years, with newly diagnosed type 2 di abetes mellitus, that were 
enrolled in the Treatment Options for type 2 D iabetes in Adolescents and Youth (TODAY) 
study.  T he TODAY trial was a multicenter clinical trial designed to evaluate the relative 
efficacy and safety of three treatments for type 2 diabetes in a demographically diverse cohort of 
youth.70 Mean minutes per day of sedentary behavior, light intensity, and moderate-vigorous 
intensity physical activity from both a subjective recall questionnaire, the 3 D ay Physical 
Activity Recall (3DPAR) and an objective measure (the ActiGraph AM7164 accelerometer) will 
be presented and compared. Relative and absolute comparisons of activity data from the 3DPAR 
and the accelerometer, using baseline results from the TODAY study cohort, will be made within 
gender categories. The effect of other variables, including age, race/ethnicity, and age/gender 
adjusted body mass index (BMIz-score), on the degree of reporting bias will also be considered. 
This will be part of a larger research effort, that goes beyond the scope of this dissertation by 
comparing physical activity and sedentary behavior levels of the TODAY youth to similar age/ 
gender youth without reported diabetes in NHANES 2005-06. 
2. Determine and report differences in the identification of valid wear time and mean daily 
time in various physical activity intensities and sedentary behavior resulting from minor 
changes in the definition of non-wear used in accelerometer data processing in an adult 
population. 
During the examination of the youth population outlined above a small coding error in 
the SAS programming was discovered, related to the identification of accelerometer non-wear. 
Non-wear is defined as time when the monitor is recording, but is not actually being worn. 
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Identifying non-wear for accelerometer data is important because otherwise time when the 
monitor was not worn can be confused with inactivity.  
Small changes to the code, which effectively changed the definition of non-wear, were 
found to be capable of causing larger than expected differences in the results of the analyses both 
in (a) the number of participants whose data was included in the final reporting of activity-
related outcome variables and (b) in the actual reported values for time spent in different 
intensities of activity, and in sedentary behavior. As a result, prior to conducting the analysis of 
data for the adult population (outlined in aim 3), it was decided that an assessment of the effects 
of non-wear equations should be conducted in an adult population to determine how this may 
impact on the original second aim of this dissertation.  
Therefore, analyses were designed to examine the effects of making small changes to the 
definition of non-wear used in accelerometer processing on the resulting assessments of physical 
activity and sedentary behavior. Activity-related outcomes, including average total counts per 
day, average counts per minute, and mean minutes per day of wear time, sedentary behavior, 
light intensity activity, and moderate-vigorous intensity activity, were reported from the results 
of three different data processing algorithms. All three algorithms utilized the same basic 
definition of non-wear; 60 consecutive minutes with zero accelerometer counts. However, each 
data processing algorithm utilized a different variation of the 60 minute definition. The most 
common variations were used, in order to assess how minor changes to the definition of non-
wear affect differences in the reporting of activity and sedentary behavior for a given population. 
This effort utilized data from adults aged 20 years and older in the National Health and Nutrition 
Examination Survey (NHANES) 2005-06 data collection cycle. NHANES is a cross-sectional 
observational study of the United States population conducted by the National Center for Health 
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and Statistics (NCHS) of the Centers for Disease Control (CDC).  The NHANES dataset was 
chosen for this effort because it is a large, publically available data set with accelerometer data 
and provides a representative sample of the United States population provided that elements of 
the complex survey design are accounted for in the analyses.  Examinations of the direct effects 
of the differences in classification of non-wear on the identification of valid minutes and valid 
days were conducted. Differences between the resulting values for activity variables produced by 
the three variations of the non-wear definition were compared, both in relative and absolute 
terms. Additionally, these differences were examined for the population as a whole as well as by 
age, gender, and body mass index (BMI) groups. 
3. Report physical activity and sedentary behavior levels in adults with impaired glucose 
tolerance and type 2 diabetes using an objective measure of physical activity capable of 
capturing all intensity levels of physical activity and sedentary behavior and compare the 
results to a nationally representative sample of adults. 
Cross-sectional physical activity and sedentary behavior levels for a cohort of adults with 
impaired glucose metabolism and type 2 diabetes mellitus will be presented in manuscript 3. The 
data for this effort is from the Diabetes Prevention Program Outcomes Study (DPPOS); a 
multicenter study conducted at sites throughout the United States. The DPPOS is a follow-up 
study of the original Diabetes Prevention Program (DPP) cohort. The DPPOS was designed to 
assess the long-term effects of interventions used in the DPP on t he development of type 2 
diabetes and its complications.  More specifically the data for the analyses was collected as part 
of an ancillary study, within the DPPOS, to collect accelerometer data on DPPOS participants in 
an effort to better define the relationship between physical activity and type 2 diabetes.  
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 In this effort accelerometers were used to objectively measure physical activity and 
sedentary behavior levels in the DPPOS cohort. Additionally, comparisons of activity and 
sedentary behavior levels between the DPPOS cohort and a representative sample of the US 
population, from the combined NHANES 2003-04 and 2005-06 data collection cycles, were 
performed to provide a context for the results from the DPPOS cohort. Comparisons to 
individuals in NHANES grouped by diabetes status were also included.  
 This research effort will help to characterize physical activity and sedentary behavior 
levels in populations with impaired glucose tolerance and type 2 diabetes mellitus by reporting 
objective activity data from accelerometers for two demographically diverse populations of both 
youth and adults. Additionally, comparisons to population weighted estimates of physical 
activity and sedentary behavior from NHANES will provide additional insight into how levels of 
physical activity and sedentary behavior differ between groups of individuals with and without 
diabetes. Finally, assessing the validity of measurement methods used to collect data on physical 
activity and sedentary behavior will help to guide future research efforts aimed at examining the 
associations between diabetes development and physical activity of all intensities, as well as, 
sedentary behavior.   
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2.0  GLUCOSE METABOLISM & TYPE 2 DIABETES 
2.1 OVERVIEW OF GLUCOSE METABOLISM  
Glucose is an important biomolecule that is utilized by the cells of the body as a major 
source of energy and as a metabolic intermediary in the production of starches, cellulose, and 
glycogen.71 Biomolecules are defined as chemical molecules that occur naturally in the body. All 
biomolecules can be classified according to four general categories: Carbohydrates 
(sacchrarides), lipids (fats), proteins, and nucleic acids.72  Glucose is considered to be the most 
commonly occurring carbohydrate and has a chemical structure of C6H12O6.
73  Along with 
galactose and fructose, glucose is considered a “si mple carbohydrate” or monosaccharide 
because it represents the smallest possible unit of a saccharide.72 
Glucose is taken into the human body through food consumption and then processed by 
the cells utilizing either anaerobic or aerobic respiration.73 Normal glucose metabolism can 
follow several pathways.74 Among these are glycolysis, which results in the release of energy, 
glycogenesis, which results in the storage of energy, glucogenolysis, which results in the 
conversion of stored energy into glucose and glucogeneogenisis, which results in the breakdown 
of simple organic compounds, such as amino acids, into glucose. After compounds are broken 
down into glucose they are then made available for glucose-dependent tissues such as the brain, 
muscles, and red blood cells.  
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Proper glucose metabolism requires a process of regulation to ensure a steady level of 
glucose within the body.71 The hormone, insulin, is the primary regulator signal for glucose 
uptake in animals and therefore is a key component in the regulation process. Insulin first 
originates in the pancreatic β cells as proinsulin, and is created during proinsulin cleavage. Most 
insulin is metabolized by the liver. Insulin secretion occurs when a g lucose molecule is 
transferred into the pancreatic β cells. In normal glucose metabolism, insulin secretion will occur 
when there is any increase in the concentration of β cell glucose above the fasting level.71 During 
this process the β cells will first release stored insulin. However, if the amount of glucose is large 
enough the β cells will increase production of new insulin. The magnitude of production will 
depend largely on the quantity of glucose. The inability of the β cells to secrete enough insulin is 
referred to as β cell dysfunction. Insufficient secretion by the β cells will cause a dysfunction in 
glucose metabolism that will ultimately result in higher blood glucose levels.  
During times of non-fasting most glucose metabolism takes place in the peripheral 
insulin-sensitive tissues, such as the muscles and adipose tissue.71 However, glucose metabolism 
during fasting takes place primarily in the non-insulin sensitive tissues like the brain.74 This is 
due to a decrease in basal insulin levels in the peripheral insulin-sensitive tissue that results in a 
decreased uptake of glucose. The steady state of glucose essential to brain function is provided 
by the slow release of glucose by the liver (and the kidneys), at a rate of about 7-10 g/hour which 
is consistent with the amount required by the consuming tissue.74 This hepatic metabolism 
involves the breakdown of other compounds to release glucose through the processes of 
glycogenolysis and gluconeogenesis. Glucose metabolism that does take place in the muscles 
and fat during fasting is anaerobic and utilizes lactic acid and free fatty acid in the processes of 
glycogenolysis and glycogeogenesis. 
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2.2 INSULIN RESISTANCE  
Insulin resistance is a condition in which the normal response of insulin to glucose is 
decreased causing a dysfunction in glucose metabolism.71 This will result in an increase in 
circulating blood glucose. Insulin resistance in the liver leads to reduced production and storage 
of glycogen. If there is little or no glycogen the cells will secrete more glucose leading to the 
over-secretion of glucose by the liver. Insulin resistance in the muscles and adipose tissue will 
reduce glucose uptake in these cells.71 As with the liver, it will also cause a loss of stored energy. 
Insulin resistance in the adipose tissue can also affect the ability of the cells to uptake lipids. This 
will result in an increase of free fatty acids (triglycerides) into the blood stream. As the condition 
of insulin resistance worsens, the bodies need for insulin increases. Eventually, the pancreas will 
lack the ability to produce enough insulin to ensure that an adequate level of glucose metabolism 
is occurring. This often leads to a chronic state of glucose metabolism dysfunction. 
Proper function of glucose metabolism in typically identified through direct testing of 
blood glucose levels.75 Because normal blood glucose levels vary in relation to the pattern of 
glucose intake, different measures of normal blood glucose have been devised for tests 
conducted during fasting and non-fasting hours. Normal blood glucose levels during fasting are 
considered to be 65 mg/dl- 99 mg/dl.75 Non-fasting levels are usually taken 2 hours after a 75 
gram glucose solution is administered to a patient orally. The glucose solution is designed to be a 
controlled simulation of a meal. Normal blood glucose levels for this type of post-load test are 
considered to be 65 mg/dl -139 mg/dl.75 Higher or lower levels are thought to indicate 
impairment in the metabolic process.  B oth low blood sugar levels (hypoglycemia) and high 
blood sugar levels (hyperglycemia) are typically considered to be indicators of an underlying 
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condition that is responsible for the metabolic impairment. A more thorough evaluation of the 
definition of type 2 diabetes mellitus is provided in the following section. 
2.3 TYPE 2 DIABETES MELLITUS 
Worldwide, the most common condition involving an impairment of glucose metabolism 
is type 2 diabetes mellitus. In general, diabetes is a condition of chronic hyperglycemia that is 
caused by defects in insulin secretion, and/or insulin action. Type 2 diabetes is a sub-
classification of the disease that typically results from insulin resistance and/or β-cell 
dysfunction. This classification of diabetes is marked by relative insulin deficiencies that often 
do not require insulin therapy initially.1  
 
Table 2.1 Criteria for the diagnosis of diabetes mellitus (American Diabetes Association Criteria) 
 
*In the absence of unequivocal hyperglycemia, criteria 1–3 should be confirmed by repeat testing. 
NGSP:National glycohemoglobin standardization program,  DCCT: Diabetes control & complications trial, 
OGGT: Oral glucose tolerance test 
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Type 2 diabetes is typically diagnosed through examination of blood glucose levels using 
one of three basic blood tests: fasting plasma glucose (FPG), 2-hour post-load plasma glucose 
(OGTT), or hemoglobin A1C (A1C). The current American Diabetes Association criteria for the 
diagnosis of diabetes mellitus can be found in Table 2.1. 
Because β cell dysfunction and insulin resistance are typically progressive disorders, 
individuals with blood glucose levels above the normal range, but below the diagnostic level for 
diabetes are considered to be at high risk for future development of diabetes. Individuals in this 
category are considered to have impaired glucose tolerance and are often referred to as p re-
diabetic. 
A staggering increase in the number of diabetes cases h as occurred since international 
attention was brought to the epidemic in the late 1980’s.4-6  Currently, the World Health 
Organization (WHO) estimates that 346 million people worldwide have diabetes with 90% of the 
estimated total being attributable to type 2 diabetes.3  This represents an increase of more than 
50% since 1995 when the number of estimated cases of type 2 diabetes worldwide was estimated 
to be 135 million.4,5 Current projections now estimate that as many as 380 million people will 
have type 2 diabetes and another 418 million people will have impaired glucose tolerance by 
2025.6,7 Cost projections indicate that global spending on diabetes was 12% of all health 
expenditures in 2010 at a price of more than 376 billion dollars (US). This spending is expected 
to increase to 490 billion dollars (US) by 2030.14 
Estimates based on da ta collected in 2010 i ndicate that about 8.3% of the total US 
population has diabetes.(CDC FACT SHEET). This is up f rom 6.3% in 2002 and 5.1% in the 
early 1990’s when reported rates began to rise.76,77 Approximately, 90-95% of diabetes cases 
among adults in the US are attributed to type 2 diabetes. The American Diabetes Association 
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(ADA)  estimated that the economic cost of diabetes in 2007 was 174 billion dollars (US).12 This 
represents a marked increase from economic cost analysis of diabetes expenditures for 1997 (98 
billion US)13 and 2002 (134 billion US).78  
The development of type 2 di abetes usually takes place over a period of years and is 
thought to be the product of a combination of personal risk factors that involve both inherited 
susceptibility and environmental/lifestyle related factors. The primary risk factors for the 
development of type 2 diabetes included impaired fasting glucose, physical inactivity, 
overweight/obesity, age, race/ethnicity and genetics, and previous gestational diabetes. 15Some 
risk factors for type 2 diabetes are unavoidable. However, other risk factors such as 
overweight/obesity and physical inactivity are considered to be modifiable and can therefore be 
targeted in prevention and intervention efforts to reduce the risk of developing diabetes, slow 
down the disease progression, and/or reduce risk for complications in patients with diabetes.15  
Currently, there is strong evidence that weight reduction in overweight/obese individuals 
can reduce the risk of developing diabetes. Several clinical trials, including The Diabetes 
Prevention Program (DPP), have shown that even moderate weight loss of 5-10% of body weight 
can prevent or delay the onset of type 2 diabetes in individuals that are considered at high risk.16-
18,79,80  Additionally, studies of bariatric surgery have also shown a significant improvement in 
blood glucose levels following the substantial weight loss associated with bariatric surgical 
procedures.81-83 
It is also likely that physical activity has a direct effect on diabetes development that is 
independent of weight loss. Evidence for the association between physical activity, sedentary 
behavior, and type 2 diabetes are presented in chapter 4. 
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Individuals that do d evelop diabetes are known to be at higher risk for certain 
complications. The most common complications of diabetes are macrovasular complications 
related to cardiovascular disease (CVD), such as angina, myocardial infarction, stroke, peripheral 
artery disease, and congestive heart failure.7  The relative risk of developing cardiovascular 
disease has been shown to be twice as high in women, and more than 1.5 times as high in men 
with diabetes compared to those without diabetes.84,85  Other common complications of diabetes 
are blindness, renal failure, and lower limb amputations all of which are caused by microvascular 
complications that include nephropathy, retinopathy, neuropathy, and small vessel 
vasculopathy.7,10 
As a result of the many complications associated with diabetes, the mortality statistics for 
individuals with diabetes are somewhat different than the general population. CVD is still the 
leading cause of death among patients with type 2 di abetes. However, CVD death rates are 
higher in individuals with diabetes, accounting for more than 50% of all deaths.76 It has been 
suggested that individuals with diabetes are 1.80 (95% CI 1.71, 1.90) times more likely to die of 
any cause and 2.32 ( 95% CI 2.11, 2.56)  times more likely to die of vascular causes when 
compared to individuals without diabetes.11  It has been estimated that middle-aged adults with 
diabetes have a reduction in life expectancy of between 5 and 10 years.86 
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3.0  MEASUREMENT OF PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOR 
IN EPIDEMIOLOGICAL STUDIES 
 
Physical activity is defined as any bodily movement that results in energy expenditure, 
including those that are planned and those that are unplanned.87 For studies conducted in free 
living individuals, physical activity is typically identified as occurring in one of several domains: 
leisure, occupational, transportation, and activities of daily living.88 Epidemiological studies that 
measure physical activity will attempt to capture information on physical activity that is 
performed in one or more of these domains. 
In addition to domain, other important aspects of physical activity are duration, frequency 
and intensity. Duration refers to the length of time spent physically active within a single unit of 
time. In activity research, duration can be used to refer to the amount of time spent in any one 
continuous episode or bout of activity, or the amount of total time spent active during a longer 
time block, such as a day or week. Frequency refers to the amount of times that physical 
activities are performed in a recorded time frame. The recording time frame is an import aspect 
of physical activity measurement and should be long enough to capture an adequate 
representation of an individual’s physical activity for a given period of time. The time period 
being represented can be longer than the recording time frame and should be determined a priori 
by the parameters of the disease outcome being examined. Finally, intensity of activity is a 
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measure of how much physical effort is required to perform an activity.60 Because intensity is a 
measure of physiological demand it is more directly related to energy expenditure than the 
frequency or duration of physical activity and therefore is often reported in metabolic equivalent 
units (METs). The metabolic equivalent is defined as t he ratio of the metabolic rate during a 
given activity to a known metabolic rate; where 1 MET is equivalent to the resting metabolic rate 
(RMR).89 It is possible to convert values in METs to energy expenditure.90 However, this can be 
problematic due to the fact that assigned MET values for intensity of activity are based on 
population averages and may not be applicable for a given individual. Therefore, physical 
activity intensity is usually reported in METs per minute, METs per hour, or as a relative 
measure that is based on assigned MET values.91 Table 3.1 illustrates the most commonly 
utilized MET-based intensity categorization scales for adults and children. Other scales, such as 
those based on an individual’s maximum aerobic capacity (instead of age) have been proposed, 
but are not as widely used.90,92  
 
 
Table 3.1 Activity Intensity Categories for Adults, Children and Adolescents 
 Intensity category 
 
Sedentary Light Moderate Vigorous 
Adults (age 18+) 91 1-1.59 METs 1.6-2.99 METs 3-5.99 METs ≥6 METs 
Children   
& Adolescents 93 
1-1.59 METs 1.6-3.99 METs 4-6.99 METs ≥7 METs 
    METs: Metabolic equivalent units 
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Most sedentary behaviors involve sitting or lying down, while light housework or slow walking 
would be consistent with light intensity activity. Brisk walking would be considered a moderate 
intensity activity and running would be equivalent to vigorous intensity activity. 
In public health recommendations, physical inactivity is often used to refer to a broader 
pattern of behavior that is marked by low levels of physical activity and/or has an excess of time 
spent sitting, or sedentary. In epidemiological research, the term “ physical inactivity”  refers to a 
state in which body movement is minimized.94 This would include sleeping, as well as, activities 
performed during waking hours that result in lower levels of energy expenditure. Physical 
inactivity that takes place during waking hours is typically referred to as sedentary behavior.40 
Understanding the roles of both physical activity and sedentary behavior in disease pathways 
requires methods that can accurately report low intensity activities in addition to moderate and 
high intensity activities. Therefore, intensity of activity can have important implications on 
which method of assessment is the most appropriate for a given research design. In general, 
measurement methods that do not  adequately capture information on f requency, duration, and 
intensity will result in less precise or inaccurate assessments of both physical activity and 
sedentary behavior. 
3.1 SUBJECTIVE MEASURES- SELF-REPORT 
Measurement methods that can be affected by the opinions or perceptions of the 
participants, proxy reporters, interviewers, or investigators are called subjective measures. 
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Questionnaires, interviews, activity diaries, and direct observation are all, commonly used, 
subjective measures of physical activity.   
Self-reported questionnaires are the most frequently used method of measuring physical 
activity and sedentary behavior in epidemiological studies.55,95,96  The popularity of the 
questionnaire is due mainly to design flexibility and a low degree of burden for both the 
participants and the investigators.55,56 Additionally, questionnaires have been shown to be a valid 
and reliable tool for measuring moderate-vigorous physical activity across a wide range of 
populations.95  However, because questionnaires are dependent on self-report they can be 
influenced by response bias (participant opinions, perceptions, and issue of social desirability). 
Questionnaires that inquire about past activity may also be subject to recall bias. In general, 
problems with poor recall seem to be more of a problem in specific populations, such as children 
or older adults and therefore may have less of an effect on the general adult population.97,98 Also, 
poor recall can have a differentially greater effect on less structured activity, which can result in 
a decreased ability of questionnaires to capture low intensity activities, which are more likely to 
be unstructured.55,58,99 
Three important design elements of questionnaires are complexity, time frame, and 
activity type. The complexity of a questionnaire will be affected by the number of questions and 
the level of detail/length of questions.  Questionnaires can vary in complexity from single item, 
global, questionnaires that attempt to provide a very basic understanding of physical activity to 
more complex quantitative questionnaires that attempt to provide a high degree of detail about 
activity. Although global questionnaires are very simple they can be used in a wide variety of 
situations where detailed information about activity is not needed. For example, global 
questionnaires have been used to provide relative assessments of activity by asking participants 
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how active they are compared to others their age and sex or by asking participants how much 
they watched television during a given time period (the past day, week, month, etc.) and then 
ranking the population or assigning them to ordinal categories based on t heir reported 
activity.41,100,101  
Global questionnaires can be very useful when activity variables are not the main 
variables of interest and may be useful when the goal is to control for the confounding influence 
of physical activity in other predictor/disease relationships.88 Therefore, global questionnaires are 
often incorporated within health surveillance systems. Examples of this are the physical activity 
questionnaires used in the BRFSS and YBRFSS (Behavioral Risk Factor Surveillance Systems 
for adults and youth), the G-PAQ used by the WHO (World Health Organization) health 
surveillance system, and the NHANES (National Health and Nutrition Examination Survey) 
physical activity questionnaire. Finally, global questionnaires can be useful for telephone 
interviews and other situations where a more complex survey may not be feasible.102,103 Despite 
their simplicity global questionnaires have been shown to be a valid and reliable method of 
assessing physical activity and sedentary behavior.57,101,104-106 However, fewer questions can lead 
to a greater incident of misclassification, and lack of detail regarding physical activity may limit 
the scope of the analysis and results.102,106 
More complex questionnaires provide a greater level of detail about the physical activity 
and sedentary behavior of individuals. This enables researchers to explore questions that require 
information on i ntensity levels, frequency, and duration over longer time frames. Therefore, 
complex questionnaires can provide a better quantitative assessment of activity. Complex recall 
questionnaires that ask participants to report past activity and include details about intensity, 
duration, and frequency for a given period of time are often referred to as quantitative activity 
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histories.55,107-109 Quantitative histories can be used to examine patterns of activity over a long 
period of time. This is useful in epidemiological research because regular patterns of physical 
activity and sedentary behavior assessed by questionnaire have been associated with many 
chronic disease outcomes, such as type 2 diabetes and cardiovascular diseases.45,110-112 
Additionally, complex questionnaires are useful for their ability to provide details on the types of 
activities performed, and the context in which activities may have been performed.55,56,113-116 
The recording time frame utilized in a complex questionnaire should be long enough to 
capture an adequate representation of an individual’s physical activity and/or sedentary behavior 
for a given period of time. The time period being represented can be longer than the recording 
time frame and should be determined a priori by the parameters of the disease outcome being 
examined. Because many chronic diseases have been linked to long term patterns of physical 
activity the goal of many physical activity questionnaires in chronic disease epidemiology 
studies is to assess “usual” activity. Therefore, the recording time frame will typically be shorter 
than the recording period that it represents. This is important because shortening the time frames 
of assessment can add bias to estimates of “usual” physical activity if external factors such as 
seasonal change and illness are not considered in the research design.55 Therefore, obtaining 
more precise estimates of physical activity and sedentary behavior may require the inclusion of 
questions that can assess the potential for confounding factors or that report activity over both 
shorter and longer periods of time. 
However, some research questions only require an assessment of physical activity and 
sedentary behavior over a shorter period of time such as a day, week, or month. In these cases, it 
may be possible to utilize a question with a recording time frame that is closer or even identical 
to the time period of interest. Examples of this would be hypotheses involving the short-term 
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effects of physical activity and/or sedentary behavior on biomarkers, such as cholesterol, insulin, 
or inflammation markers. 
Activity type is often used to refer to categories of activity based on either domain or 
intensity of activity. In studies that are designed to assess the quantity of physical activity 
performed, it is necessary to capture an accurate assessment of all types of activities that elicit 
the greatest energy expenditure in the target population. In heterogeneous populations, like the 
United States population, it is usually necessary to capture information from more than one 
domain. Assessing activity in more than one domain can also be important when comparing two 
different populations. One example of this was a study of the relationship between serum insulin 
levels and physical activity in two ethnically and culturally disparate populations; the Pima 
Indians in Arizona and the occupants of Mauritius, an island nation in the Southwest Indian 
Ocean.117 Both leisure and occupational activity were essential in this comparison because the 
Pima accumulated most of their physical activity from leisure time activities while the 
inhabitants of Maritius accumulate over 90% of their physical activity from occupational 
activity. If activity had been assessed in only the leisure or the occupational category alone, the 
results of the study may not have revealed the true relationships between activity and serum 
insulin levels in both populations.  On the other hand, in a population that is very homogeneous 
for a specific domain on activity (work, leisure, etc.), it may not be necessary to capture activity 
in that domain if the goal of the analysis is to provide a valid ranking of individuals, based on 
their physical activity levels. 
Intensity level provides another means by which to categorize different types of 
activities. While some questionnaires have shown to be valid for measuring moderate-vigorous 
activity and planned sedentary behavior (such as watching TV, work sitting, and leisure screen 
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time) they are less accurate at providing assessments of light intensity activities and unplanned 
sedentary behavior.55,57,58 Although many surveys do not  attempt to provide quantitative 
assessments of light intensity activity and unplanned sedentary behavior, some questionnaires 
have attempted to provide this information. Based on the current literature, it is not clear that 
questionnaires can provide valid estimates for the quantity of unstructured low intensity 
activities. Nor has it been established that adding these categories of activity/inactivity improves 
quantitative assessments of total physical activity or total sedentary behavior from 
questionnaires.40,41,55,58,99 However, questionnaires can provide valid qualitative information 
about the types of light intensity and sedentary activities performed by pa rticipants.40,116 
Qualitative data on the specific activities performed and the context of activity is also one of the 
advantages that subjective measures have over most of the currently available objective measures 
of activity. 
Reliability and validity are two criteria that provide statistical evidence for the efficacy of 
a physical activity measurement tool. Reliability is the ability of a measurement tool to produce 
consistent results.118,119 Reliability of physical activity and sedentary behavior questionnaires is 
usually established on the basis of test-retest reliability coefficients or intra-class correlation 
coefficients.60,95,97,120,121 Test-retest reliability is particularly important for studies that attempt to 
identify “usual” behavior or studies in which the assessment time frame is shorter than the time 
period of interest. 
Validity is the degree to which a questionnaire is able to measure what is was intended to 
measure.118,119 Validity of questionnaires is often established by c omparing the results of the 
questionnaire to the comparable results of other measurement methods (validated questionnaires, 
diaries, objective measures, or direct observation). This can be done within a subset of the study 
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population prior to the assessment of the full population or previously completed in a similar 
population.95,97,120-122 The comparison method used for validation should already be validated to 
assess activity in a similar population and for the same time period of interest (past month, past 
year, lifetime).  
Questionnaires designed to report total activity and activity specific to several different 
domains or intensity categories, would have to be proven valid for measuring total activity and 
activity in each category. Validity for one question or one category of activity does not prove 
that the questionnaire is valid for all the variables it reported. On the other hand, some variables 
can be shown to be valid proxy measures for other variables that are not collected. For example, 
calculating total sedentary behavior would require data on both planned and unplanned sedentary 
behavior. Questionnaires have not proven to be a valid measure of non-planned sedentary 
activity and therefore a direct, accurate measure of total sedentary is difficult to assess v ia 
questionnaire.58 However, validation studies have shown that questions designed to elicit the 
total amount of time spent watching television or the total amount of screen time per day are 
valid proxy measures for total time spent sedentary, in some populations.40,58,123 Also, a 
questionnaire found to be valid in one population may not be valid in another population due to 
differences in cognitive function, types of activities performed, or other differences between 
populations that may affect reporting.97,124,125 Therefore, it is important to carefully consider the 
study population when choosing an assessment method. 
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3.2 OBJECTIVE MEASURES- ACCELEROMETRY 
Objective measures of physical activity and sedentary behavior are used to estimate 
activity-related variables, like total physical activity, using measurements taken from 
physiological or biomechanical parameters. Although objectively-assessed physical activity can 
be biased by issues related to monitor wear compliance these methods are not subject to personal 
opinions, perceptions, or the other types of reporting bias that can affect the results of subjective 
measures of physical activity and sedentary behavior.60 As a r esult, objective measures are 
generally better at capturing unplanned activities and can provide a m ore accurate picture of 
behaviors that occur at the lower intensity end of the physical activity spectrum.59 This also 
makes it possible to produce a better quantitative assessment of total physical activity. Objective 
measures to assess physical activity include physiological monitors, such as heart rate monitors, 
and motion detectors, such as pedometers, accelerometer, and GPS (Global Positioning System) 
devices.90,126,127 These monitors can be used individually or data from several devices may be 
combined. 
Currently, the most commonly utilized objective measure of physical activity is the 
accelerometer. Accelerometers are a type of motion detector that is capable of recording both 
movement and speed over a period of time.128,129 The earliest accelerometers used in physical 
activity research measured movement only in the horizontal plane, but currently there are 
accelerometers available that can monitor movement in up to three planes: horizontal, vertical, 
and diagonal. Many of these devices are also equipped with an inclinometer that can record 
whether or not a participant is lying, sitting, or standing. 
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Accelerometers operate by calculating the acceleration along a g iven axis.128 The 
information necessary to calculate the acceleration is typically provided by a  piezo-electric, 
micro-mechanical spring, or an electrical capacitance system.129,130 All monitor types convert 
movement into an electrical signal which is output by the monitor as a count. The greater the 
amount of movement within a given period of time, the greater the number of counts that are 
output for that time period.  
Previous research has compared the number of counts accumulated during various 
activities to measured oxygen uptake. Prediction equations were then developed from regression 
models to create cut-points in accelerometer counts that correlated with known MET-based 
intensity cut-points used in physical activity research (sedentary, light, moderate, and 
vigorous).131 The number of counts from the monitor for each recording period (e.g. a minute or 
second) can therefore be calibrated to match pre-existing MET-based intensity scales for activity. 
As a result, the accelerometer readings can be utilized either as raw counts or as time spent in 
different intensity levels of activity.  
Figure 3.1 provides the resulting values from an accelerometer calibration study by 
Freedson et al.131 The Freedson established cut-points for light intensity (1-3 METS), moderate 
intensity (3-6 METS), and vigorous intensity (>6 METS) physical activity are associated with 
accelerometer cut-points of 100-1951, 1952-5723, and greater than 5724 counts.131 
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Currently, there are many types of accelerometers on t he market for use in physical 
activity research.132 Different monitors may have different mechanisms of measurement, record 
different variables, and have different body placement.129,130,132 Also researchers may use 
calibration data from different regression models for converting data from the monitor to a 
variety of MET-based intensity scales.131,133-136 For consistency, most research studies require 
that the accelerometers be worn on the same part of the body for all study participants. This is 
because the placement of the monitor will affect which types of movement it will record. The 
monitors are typically attached to a person’s waist, in line with their armpit or at the small of the 
back, with a clip or belt.137 However, some monitors are worn on the upper arm, wrist, thigh, 
Figure 3.1 Freedson cut-points for accelerometry & the corresponding MET-based 
physical activity intensities 
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ankle, or shoe. Monitors attached at the waist will record truncal movement well, but may not 
accurately report all upper body movement. Likewise, monitors placed at the wrist, ankle, or foot 
will pick-up more of the smaller movement that occurs in the extremities, but may not 
differentiate well between these movements and truncal movements that represent greater energy 
expenditure.  P hysical limitations of the population should be considered when choosing a 
monitor location. For example, some monitors may not provide an accurate assessment of 
activity for individuals with impaired ambulation and therefore may not be appropriate for some 
individuals or populations.  
Also most monitors are not waterproof and therefore cannot be worn during aquatic 
activities such as swimming and water aerobics. Even those monitors that can be worn in water 
have difficulty adjusting for the uneven forces exerted by the water and may not provide an 
accurate reading of movement or intensity. Other general limitations of accelerometers include 
participant burden, cost, equipment malfunction/ noncompliance, and the possibility that wearing 
the monitor may cause the participant to alter their physical activity patterns.  
Monitors that may be removed during the recording timeframe need to have estimates of 
physical activity and sedentary behavior adjusted for the time when the monitor was actively 
recording, but was not worn by t he participant (non-wear time). Most research efforts utilize 
monitor specific, automated computer algorithms developed to identify and remove monitor non-
wear.  
Although using an automated process to remove non-wear has been shown to reduce bias 
in reported non-wear time, the algorithms themselves have also been shown to be a source of 
bias.61,64,66,67,138,139 Validation studies have suggested that there may be more than one 
appropriate algorithm for a given monitor.61,138 However, it is not clear whether all algorithms 
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produce comparable results. Additionally, little effort has been put toward validating non-wear 
algorithms for use in different population sub-groups.64 Therefore, it is not clear if the currently 
used algorithms are valid for all sub-groups. 
Despite the limitations of accelerometers they are currently considered to be one of the 
best methods for assessing free living physical activity. Accelerometers have been proven to be a 
reliable and valid measurement of physical activity and sedentary behavior in many different 
types of populations including children140-144, adults145-148, and older adults149-152. Currently, there 
is no measure of physical activity considered to be a “gold standard” in free living conditions. 
However, accelerometers are the device that is most frequently used to validate other physical 
activity measures, including pedometers and questionnaires.153-157 
3.3 PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOR ASSESSMENT IN 
CHILD AND ADOLESCENT POPULATIONS 
The following section is not meant to serve as a co mplete outline of assessment in 
children and adolescents, but as a guide to specific issues that must be considered in addition to 
the issues for the general population already discussed above. 
Choosing a proper assessment tool in children and adolescents requires an understanding 
and consideration of the cognitive, physiological, and behavioral differences between adult 
populations and child and adolescent populations. Although some differences in children and 
adolescents only affect specific measurement methods, other issues, such as the higher drop-out 
rates and poorer compliance typically reported in younger populations are factors that can affect 
all types of measurement methods. Furthermore, changes that occur throughout childhood and 
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adolescents must be considered when choosing a measurement method, deciding how that 
method with be implemented, and interpreting the results, for a given youth population. 
For self-report measures, reliability and validity studies for youth populations have 
provided widely varying results for both reliability (0.56-0.93) and validity (0.03-0.89) 
coefficients.97,120,158,159   Problems that are amplified in youth populations that may contribute to 
the wide range of coefficients values are poor compliance and cognitive difficulties, such as poor 
recall and missing values.121,160  Also, over-reporting of physical activity and under-reporting of 
sedentary behavior on self-report measures is thought to be a larger problem in youth when 
compared to reporting in adults.161-165 This increase in misreporting may be due in part to the fact 
that physical activity in youth populations tends to be more unplanned and sporadic, occurring in 
shorter bouts.166 This is particularly true in pre-adolescent populations and can make it difficult 
to accurately assess physical activity and sedentary behavior with questionnaires.  
Due to cognitive and behavioral factors, the specific age range of the population being 
assessed is particularly important in youth.  The reliability and validity of self-report measures of 
activity and sedentary behavior for children under 11 y ears of age is generally lower when 
compared to older children.158 Proxy reporting of physical activity and sedentary behavior by an 
adult, such as a parent or caregiver, has been used in an attempt to improve reporting for younger 
children. 
However, the results of reliability and validity studies for proxy reporting measures have 
been mixed.120,163,167 Therefore, the effectiveness of these methods is not clear. Interviewer 
administration, on the other hand, has been shown to improve the reliability and validity of recall 
questionnaires in older children and adolescents.121,159 However, this method may still not be 
feasible for younger children and adds additional burden to the investigators.159  
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Finally, analysis that requires converting activities into MET-based intensity categories 
must consider the fact that children and adolescents are physiologically different than adults. 
Previous research indicates that resting energy expenditure is higher in youth when compared to 
adults.168,169 Additionally, studies of youth and adults suggest that the energy cost of activity is 
higher in youth when compared to adults.170-172 Therefore, MET-based conversion tables 
designed for children and adolescents, such as the compendium of physical activity for youth, 
should be utilized when converting reported activities into MET-based categories of physical 
activity.93 
Currently, accelerometers are the most widely used measurement tool for capturing 
physical activity and sedentary behavior in child and adolescent populations. Advantages of the 
accelerometers over self-report are the smaller recording epochs that can capture the sporadic 
nature of children’s activity and the fact that they are not as affected by the amplified cognitive 
difficulties reported in child and adolescent populations.  
However, there are several issues that should be considered when assessing physical 
activity and sedentary behavior in child and adolescent populations, using accelerometry. The 
first issue is that the activity of children and adolescents tends to be more varied, when compared 
to adult activity.163,173 This is true for the types of activities performed, the directions of 
movements, as well as, the patterns of behavior over the recording time frame. Although there is 
no consensus at this time, there is some evidence that monitors with more axis and shorter epoch 
times may be better at capturing the varied activity of child and adolescent populations.132,174,175 
It has also been suggested that to capture an accurate representation of “typical behavior” from 
activity monitors, 4 or  more 10 hour days of data are required from youth, as opposed to 3 or  
more 10 hour days, as is required in adults.121,132,176 However, this finding is based on data from 
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generally healthy youth populations and is rooted in the fact that youth in the examined 
populations vary their activity more from one day to another than adults. Finally, different 
accelerometer count based cut-points have been derived for youth, based on t he premise that 
there are physiologically based differences in how movement relates to MET-based intensity 
categories of physical activity and energy expenditure that shift throughout childhood and 
adolescents.69,177-180 
3.4 PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOR ASSESSMENT IN 
POPULATIONS WITH DIABETES 
Few studies have attempted to identify methodological issues specifically related to the 
measurement of physical activity and sedentary behavior in populations with type 2 
diabetes.181,182 The results of these studies do not specifically indicate a need for a consideration 
of type 2 diabetes diagnosis when considering, interpreting, or assessing methods of 
measurement for physical activity and sedentary behavior. However, there are specific risk 
factors and complications associated with type 2 di abetes that have been previously linked to 
biased estimates of  physical activity and sedentary behavior that should be addressed. The most 
important of these include overweight and obesity, poor ambulation and/or gait abnormality, and 
differences in activity patterns (when compared to non-disease populations). 
Overweight and obesity are among the most important risk factors for type 2 di abetes. 
Studies of subjective measures of physical activity and sedentary behavior have shown that 
reporting bias on questionnaires may be more pronounced in overweight and obese individuals 
than it is in normal weight individuals.162,183-185 This was found to be true in both adult and 
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adolescent populations. Studies of objectively measured physical activity in overweight and 
obese populations reported that central adiposity can cause a tilt in waist and hip worn monitors 
that can hinder the ability of spring-levered pedometers to work properly and therefore cause an 
underestimation of activity.186-188 However, studies in accelerometers and accelerometer based 
step-counters have shown that for most monitor types the effect of tilt angle is not significant.188-
192 Also, analyses that attempt to convert accelerometer results into energy expenditure should 
consider the fact that body mass effects energy expenditure. Although the current conversion 
equations take weight into account, there is evidence that these equations may not provide 
accurate estimates for overweight and obese individuals.189,193-195 In relation to this, Ainsworth et 
al.91 originally suggested that the MET-based values associated with each intensity level were 
not intended to produce accurate assessments of energy expenditure for individuals. The 
compendium values were designed to represent population averages that could be used to 
standardize survey data and may not be applicable to certain individuals without adjustments for 
personal factors, such as obesity.  
Neuropathy, a common complication in type 2 diabetics, can lead to gait abnormalities 
and poor ambulation. Poor ambulation and gait abnormalities can affect the types of activities 
performed by individuals in a population. Furthermore, monitoring devices that are designed to 
record ambulatory activities do no t provide meaningful results for individuals who are non-
ambulatory. Additionally, it has been shown that some monitoring devices do not  accurately 
record activity in individuals with gait abnormalities.196-198 Therefore, the disability of the 
specific study population being examined should be considered when designing questionnaires 
or determining monitor type and placement. 
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Currently, population based studies have suggested that adults, children, and adolescents 
with type 2 diabetes are more sedentary and spend less time in high intensity activities than their 
non-diabetic counterparts.199-203 Therefore, research efforts designed to capture physical activity 
and sedentary behavior in populations with type 2 di abetes should consider methods that can 
capture all intensities of physical activities well.  As a r esult, it may be necessary to examine 
differences in physical activity and sedentary behavior variables to determine if there are 
additionally considerations in the reporting of physical activity and sedentary behavior that need 
to be addressed within these populations specifically. As part of this analysis effort, we will 
attempt to expand the understanding of methodological issues in physical activity measurement 
that may be important for populations of individuals with impaired glucose metabolism or type 2 
diabetes mellitus. 
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4.0  TYPE 2 DIABETES MELLITUS, PHYSICAL ACTIVITY, AND SEDENTARY 
BEHAVIOR 
4.1 BIOLOGICAL CONNECTION 
The biological role of physical activity on maintaining healthy glucose metabolism is not 
completely understood. However, there are physiologic processes involving physical activity that 
are thought to play a role in maintaining normal glucose metabolism. First of all, it has been 
shown that exercise increases insulin uptake in the muscles. This may be due in part to the 
increased availability of GLUT4, a transporter carrier proteins utilized by hum ans and other 
mammals.30 The greater availability of this protein allows for an increase in the rate of glucose 
metabolism. The increase in blood flow during exercise may also increase the rate at which 
insulin is delivered to the working muscles. Both insulin and exercise cause translocation of 
GLUT4 from an intercellular compartment to the surface of the cell which is a necessary step in 
glucose uptake.30 Because the signaling pathways are different for the insulin and exercise 
induced uptake of glucose it is possible to increase insulin uptake via exercise even if there is a 
dysfunction in the signally pathway related to insulin induced uptake.28,29,31,204  
In addition to the evidence for the positive, exercise induced, effects of physical activity 
on the body, there is evidence that prolonged periods of inactivity, may have a negative effect on 
normal biological processes in the body.33-35,40,205 In relation to impaired glucose tolerance and 
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type 2 diabetes mellitus, the results of several studies suggest that inactivity has a st rong 
influence on lipoprotein lipase (LPL) activity in skeletal muscles.33-35 LPL is an enzyme that is 
necessary for hydrolysis of the triglyceride contained in lipoproteins. LPL binds to circulating 
lipoproteins when present on the vascular endothelium.  Higher circulating levels of LPL in 
skeletal muscle have been linked with higher plasma glucose levels.206,207 More specifically, 
higher levels of circulating LPL has been shown to cause preferential use of lipids as an energy 
source which can lead to insulin resistance.206,27 One study in mice and rats showed that both 
acute and chronic inactivity lead to a decrease in LPL activity in weight-bearing skeletal muscle. 
It has also been suggested that inactivity may also affect diabetes development through its 
influence on gene activation and deactivation 32, and on the regulation of β cell function.36  
4.2 PHYSICAL ACTIVITY, SEDENTARY BEHAVIOR,  AND TYPE 2 DIABETES 
MELLITUS 
There is substantial evidence from both clinical trials and epidemiologic studies for the 
effect of physical activity on the development of impaired glucose tolerance and type 2 diabetes 
mellitus. The most compelling evidence comes from clinical trials that were designed to test the 
efficacy of lifestyle interventions for reducing the incidence of type 2 diabetes. The most well-
known, of these studies, was the Diabetes Prevention Program (DPP).  T he DPP was a 
multicenter clinical trial that examined the efficacy of metformin and of a lifestyle intervention 
to delay or prevent the onset of type 2 diabetes mellitus in adults at high risk for developing the 
disease. Although both lifestyle intervention and metformin were successful for reducing the 
incidence of diabetes in the DPP, the lifestyle intervention, which included a physical activity 
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goal of 150 minutes/week of moderate-vigorous exercise, was more successful with a 58 % 
reduction in diabetes incidence when compared with placebo over an average follow-up of 2.8 
years.16 A post-hoc analysis of the DPP that attempted to separate the effects of physical activity, 
weight loss, and dietary improvement on the incidence of diabetes showed that those individuals 
who did not meet the weight loss goal or the fat goal, but did report making the activity goal had 
a 46% reduction in incident diabetes compared to those individuals that did not make any of the 
goals.38   
Other large clinical studies, including the Diabetes Prevention Study (DPS) in Finland,18 
the Da Qing study in China,26 and the Indian Diabetes Prevention Program17 have confirmed the 
findings of the DPP in a wide diversity of populations around the world. In particular, the Da 
Qing clinical trial tested the individual effects of diet and exercise by creating separate 
intervention arms for exercise and dietary modification. The results showed that over a six year 
follow-up in individuals at high risk for the disease, the reduction in risk of diabetes was 46% 
lower in the exercise group.26 A report of follow-up evidence from the DPP, DPS, and the Da 
Qing study showed that even after follow-up periods of 10,7, and 20 years , respectively, there 
was still a substantial reduction in the risk of developing diabetes for individuals who 
participated in a lifestyle intervention that included physical activity.22  
Additionally, there are many epidemiologic studies that show the positive effects of 
physical activity on diabetes related outcomes. A review of twenty prospective studies performed 
in large cohorts reported, that in all studies reviewed, there was a negative association between 
physical activity and diabetes development.208 Although a few of the studies reported no 
association in specific population subgroups,  meta-analysis that involved ten of the same 
studies, reported that based on a total of 301,221 pa rticipants and 9,267 incident cases of 
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diabetes, the summary risk reduction of type 2 diabetes was 0.69 (95% CI 0.58-0.83) for regular 
participation in moderate intensity activity when compared to being sedentary and 0.70 (0.58-
0.84) for regular walking compared to almost no walking.209 The risk reduction in this study was 
found to be significant, even after adjusting for BMI. In relation to this, a study in the Pima 
Indians of Arizona showed that there was a n egative relationship between incident diabetes 
assessed by the OGTT and total physical activity for both men and women.210 Although the 
results were attenuated by BMI, when the analysis was performed stratified by tertiles of BMI, 
the diabetes incidence rate remained lower in more active than in less active individuals from all 
BMI groups, for all but males in the middle BMI group.  Finally, another analysis that utilized 
the results of eight previously published longitudinal studies concluded that there was evidence 
for a joint effect and for independent effects of both obesity and inactivity on incident type 2 
diabetes.39 Therefore, these results indicate that improvements to physical activity can reduce the 
risk associated with activity alone, as w ell as, some of the joint risk associated with both 
inactivity and obesity.  
Although, most studies of physical activity and diabetes have focused on activities that 
are at least moderate intensity, there is also evidence for a connection between lower intensity 
activity and type 2 diabetes. First of all, there is evidence that walking, an activity that can fall 
into both the light and moderate intensity categories, can have a p ositive effect on diabetes 
related outcomes and can reduce the risk of diabetes development.209,211-214  Additionally, 
objectively reported light activity was found to be negatively associated with post-prandial 
glucose levels in Australian adults without diagnosed diabetes.44  Finally, a study in older adults 
found that reported performance of light activity, at least once a w eek, was associated with a 
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reduced risk of diabetes for those aged 70 years and greater. However, the results were 
attenuated by adjusting for important covariates.215 
In addition to the effects of physical activity on the development of diabetes, there has 
been growing evidence that reducing the amount of time spent sedentary may also have an effect 
on the development of diabetes. Currently, there are numerous studies that have linked the 
amount of time spent watching television to diabetes related outcomes and increased risk for 
diabetes development.45,216-221 Additionally, total sedentary behavior, obtained from 
accelerometer output has also been linked to diabetes related outcomes and the development of 
diabetes in several studies.36,46-48,222 Specifically, one study that examined the cross-sectional 
relationship between average total sedentary minutes per day from the accelerometer and cardio-
metabolic biomarkers in a r epresentative sample of U.S. adults found that total sedentary was 
positively associated with insulin, HOMA-%B, and HOMA-%S (p< 0.05).48 Therefore, it is now 
recognized that capturing all intensities levels of physical activity, as well, as sedentary behavior 
is important to understanding the effect of activity on diabetes development.35,40,41,214,223 
4.3 PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOR LEVELS IN 
INDIVIDUALS WITH TYPE 2 DIABETES  
The current American College of Sports Medicine (ACSM) recommendations for 
physical activity, approved by the American Diabetes Association (ADA), suggest that in order 
to reduce the risk of diabetes, adults should perform 150 minutes or more of moderate-vigorous 
physical activity per week. In general, it has been reported that most adults in the United States 
are not meeting these recommendations.224,225 Recent data on physical activity levels, 
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specifically in adults with type 2 diabetes or impaired glucose tolerance from large population 
surveys in the United States and elsewhere indicate that individuals with type 2 di abetes or 
impaired glucose tolerance are less active compared to individual without diabetes.202,226-231 In 
general, questionnaires that identify individuals as active or inactive have reported that 50-60% 
of adults with impaired glucose tolerance or type 2 diabetes are inactive compared to 
approximately 30-38% of adults without impaired glucose metabolism.202,227,229,230 
Most large, population representative studies do not collect objective physical activity 
data. However, during the 2003-04 and 2005-06 cycles of NHANES accelerometers were used to 
collect data on physical activity and sedentary behavior. One study that utilized accelerometer 
data from NHANES 2005-06 reported that average daily step counts in individuals with diabetes 
were 2183 +/- 189 versus 3668 +/- 89 in individuals without diabetes.232 Currently, there are no 
other population representative studies of adults that report accelerometer based physical activity 
data by di abetes status. Additionally, there is no population representative data on sedentary 
behavior levels for adults.  
Currently, the CDC estimates that less than 1% of the child and adolescent population in 
the United States have type 2 diabetes. Therefore, it should not be surprising that there are no 
studies, based on popu lation representative data that report physical activity or sedentary 
behavior levels for children and adolescents with type 2 diabetes. In fact, the only study that 
reports physical activity levels in a large sample of children and adolescents with type 2 diabetes 
is a paper that was generated in connection with this dissertation effort. Physical activity and 
sedentary behavior levels were generated from baseline accelerometers data files on 242 youth 
ages 10-18 who participated in the treatment options for type 2 diabetes in adolescents and youth 
study  ( TODAY) and had complete accelerometer data.233 The results of this analysis showed 
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that for most age/gender categories the TODAY youth spent less time in moderate-vigorous 
activity and for all age categories they spent more time in sedentary behavior, when compared to 
a nationally representative sample of obese youth from NHANES 2005-06.    
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5.0  PAPER #1: ASSESSMENT OF PHYSICAL ACTIVITY AND SEDENTARY 
BEHAVIOR IN YOUTH WITH TYPE 2 DIABETES 
Manuscript 1 will present estimates of baseline physical activity and sedentary behavior 
levels for youth aged 10-18 years, with newly diagnosed type 2 diabetes mellitus, that were 
enrolled in the Treatment Options for type 2 D iabetes in Adolescents and Youth (TODAY) 
study.  M ean minutes per day of sedentary behavior, moderate-vigorous intensity, and light 
intensity physical activity from both a subjective recall questionnaire (3DPAR) and an objective 
measure (accelerometer) will be presented and compared.  
5.1 BRIEF OVERVIEW OF TODAY TRIAL 
Baseline data from the treatment options for type 2 di abetes in adolescents and youth 
study (TODAY) will be used to determine the level of agreement between an objective measure 
of activity (accelerometer) and a subjective measure of activity (3DPAR questionnaire) for 
reporting time spent in physical activity and sedentary behavior in adolescents and youth with 
type 2 diabetes (manuscript 1). 
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The TODAY trial was a randomized, double-blind, parallel-group clinical trial funded by 
the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). 70 TODAY was 
designed to evaluate the relative efficacy and safety of three treatments for type 2 diabetes in 
youth:  metformin alone, metformin plus rosiglitazone, and metformin plus an intensive lifestyle 
program.  The primary objective of the trial was to compare the three treatment arms on time to 
treatment failure, defined as loss of glycemic control. 
Participants were recruited from 15 clinical centers across the United States and a total of 
1211 patients were screened.70,234 To be eligible, participants were required to be 10-17 years 
old, with less than two years of type 2 diabetes, a BMI ≥85th percentile at time of diagnosis or at 
screening, had availability and agreement of an adult caregiver to support participation, were 
negative for pancreatic autoimmunity (both GAD and IA2 antibodies), and had fasting C-peptide 
> 0.6 ng/mL.  Additionally, participants with hemoglobinopathies were excluded.  
After screening was completed 927 patients were entered into a 2 to 6 m onth run-in 
period.234 The run-in period was performed to ensure that participants could tolerate therapy with 
metformin, accomplish mastery of a standard diabetes education curriculum, and demonstrate 
ability to adhere to study requirements.70 Participants who successfully completed the run-in 
period were found to decrease their weight by a mean of 0.68 kg compared to a 0.71 kg weight 
gain in those that failed the run-in period.  
 47 
5.1.1 Measures 
5.1.1.1 Demographics 
Demographic data was collected at the baseline visit. Participants and their caregivers 
were asked to report participant’s age and self-identified racial/ethnic group as White non-
Hispanic, Black non-Hispanic, Asian non-Hispanic, Hispanic, or Native American. 
5.1.1.2 Physical Activity- Subjective 
Subjective physical activity data were measured utilizing the 3DPAR. The 3DPAR is a 
self-administered questionnaire of physical activity for the previous three days that has been 
validated in similarly aged youth.235-238 The 3DPAR was administered during the clinic visit, 
following the participant’s use of the accelerometer and asked participants to recall activity over 
the time period that coincided with the final three days of accelerometer monitoring.  T rained 
interviewers guided the process of completing the questionnaire by providing the initial 
instructions and clarifying the questionnaire.  
Based upon a list of 77 leisure, occupation, and daily living activities, participants were 
asked to record the main activity that they participated in during each 30 minute block of time, 
from 6 AM to 12 AM, for each of the past three days. They were also instructed to estimate the 
intensity level the activity was performed based upon t he following categorizations: Light 
Activity requires little or no movement with slow breathing; Moderate Activity requires some 
movement and normal breathing; Hard Activity requires a moderate amount of movement and 
increased breathing; and Very Hard Activity requires quick movements and hard breathing. 
Intensity values (METS) were assigned to each of the 77 activities and their four intensity 
levels listed on the questionnaire and were based on the Compendium of Physical Activity. 91  
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Physical activity from the 3DPAR was analyzed in terms of total hours of physical activity, total 
daily MET hours, and total time spent per day in the various intensity levels of physical activity 
(light, moderate, vigorous) and sedentary behavior. 
5.1.1.3  Physical Activity- Objective 
Objective physical activity data were collected using the ActiGraph AM7164 
accelerometer (Pensacola, FL).  This ActiGraph model is a sm all, uniaxial piezoelectric 
accelerometer that is typically worn at the waist, which measures vertical acceleration ranging in 
magnitude from 0.05 to 2.00 Gs with frequency response of 0.25 – 2.50 Hz. Data output from the 
ActiGraph accelerometer are activity counts, which quantify the amplitude and frequency of 
these filtered accelerations and were summed over a 1 -minute time interval. The sum of the 
activity counts is related to activity intensity and can be categorized based on validated activity 
count cut-points. Previous studies have demonstrated that the ActiGraph accelerometer is a valid 
and reliable measure of physical activity in children and adolescents.239 
Participants received an accelerometer prior to their clinic visit and wore the 
accelerometer for a period of 7 days. Participants were asked to record the time at which they put 
on the monitors in the morning and the time they took off the monitors at night in a physical 
activity diary.  A t the end of the 7 day period, the participant returned the accelerometer and 
physical activity diary at their clinic visit. 
Data from the accelerometer were downloaded, processed, and screened for wear time 
using previously reported methods (http://riskfactor.cancer.gov/tools/nhanes).  A verage total 
activity counts per day were calculated using summed daily counts detected over wear periods. 
Time in minutes spent in different activity intensities was calculated using age-specific count 
ranges corresponding to sedentary, light (1-3.99 METs), moderate (4-6.99 METs) and vigorous 
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intensity (≥ 7 METs). [A MET is an estimate of relative intensity such that one MET represents 
the energy expenditure for an individual at rest whereas a 10 MET activity requires 10 times that 
amount]. These intensity levels were derived from a published age specific, energy expenditure 
prediction equation. 140 The equation adjusts for the higher resting energy expenditure of youth. 
172,240  Non-wear time was defined as intervals of at least 60 consecutive minutes of zero counts, 
with allowance for up to 2 minutes of observations with greater than zero counts/minute. Wear 
time was determined by subtracting non-wear time from the total observation time for the day. 
Total activity was defined as the combination of light, moderate, and vigorous activity (≥1 
MET). Time spent in sedentary behavior was defined as the amount of wear time accumulated in 
counts below100 counts/minute. To be included in any accelerometer related analyses, 
participants must have had accelerometer data that included 10 hours of wear time on 3 or more 
valid days. 
5.1.1.4 Anthropometrics 
All anthropometric measures were taken with youth wearing lightweight clothing and 
without shoes by trained and certified research staff. Height was measured to the nearest 0.1 cm 
and weight was measured to the nearest 0.1 kg.  BMI was calculated as kg/m2 and BMI z-score 
was derived from the sex-and age-specific standards published by the National Center for Health 
Statistics. 
5.1.2  Baseline Demographic and Anthropometric Characteristics 
704 youth successfully completed the run-in period, were randomized and entered the 
main clinical trial.234 699 of the 704 individuals randomized completed the baseline assessments. 
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At baseline the cohort had a mean age of 14 yrs., mean diabetes duration of 7.8 months, and a 
mean body mass index Z-score of 2.15. The baseline cohort was 64.9% female, 41.1% Hispanic, 
31.5% non-Hispanic black, 19.6 %  non-Hispanic white, and 7.8 % o ther racial/ethnic groups. 
41.5% of the baseline cohort had a household annual income of less than $25,000; and 26.3% 
had a highest education level of parent/guardian less than a high school degree.234  
5.2  PAPER #1 OVERVIEW 
Purpose: To compare reported values of physical activity (PA) and sedentary behavior 
assessed by a recall questionnaire and an accelerometer in a diverse cohort of youth with type 2 
diabetes.    
Methods:  PA data was examined in 236 pa rticipants, in the Treatment Options for type 2 
Diabetes in Adolescents and Youth (TODAY) study, who had complete accelerometer and 3 day 
physical activity recall (3DPAR) data. 3DPAR/accelerometer agreement for total time spent 
physically active (TPA), time spent in light (LPA) and moderate-vigorous (MVPA) intensity 
activities, and time spent sedentary was compared with Spearman’s correlations and Bland-
Altman plots.  
Results: Spearman coefficients were not significant for MVPA, LPA, or TPA between 
the two measurement instruments. Sedentary time in females (r= .19, p<.05) was significantly 
but weakly correlated between instruments.   E xamining absolute differences between the two 
measures (absolute value of 3DPAR recorded minutes/day minus accelerometer recorded 
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minutes/day), the median differences were large in males and females for MVPA (50 & 52 
min/day), LPA (116 & 97 min/day), and sedentary time (136 & 177 min/day).  
Conclusions:  T he relationship between the 3DPAR and accelerometer for sedentary 
behavior and PA intensity levels was weak, at best, in overweight/obese youth with type 2 
diabetes. Reported mean minutes/day of MVPA and LPA were, in general, substantially higher 
and sedentary time much lower on the subjective 3DPAR when compared to recorded values 
from the accelerometer for both gender groups.  The differences between instruments appear to 
be driven by reported values from the 3DPAR. These results suggest that the 3DPAR may not 
provide an accurate measure of the quantity of time spent in either PA or sedentary behavior in 
overweight/obese youth with type 2 diabetes.  
 
In summary this manuscript provides an assessment of the levels of physical activity and 
sedentary behavior in a demographically diverse cohort of youth with type 2 diabetes. 
Additionally, this effort assesses the validity of the 3DPAR questionnaire for measuring both 
time spent in different intensities of physical activity and total time spent sedentary. The results 
of these analyses suggest that measurement methods for physical activity and sedentary behavior 
should be validated in populations with type 2 diabetes, even if the methods in question have 
been previously validated in the general population.  
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6.0  PAPER #2: DIFFERENCES IN PHYSICAL ACTIVITY OUTCOMES DUE TO 
ACCELEROMETER NON-WEAR ALGORITHMS 
Activity-related outcomes, including average total counts per day, average counts per 
minute, and mean minutes per day of wear time, sedentary behavior, moderate-vigorous intensity 
activity, and light intensity activity, will be reported from the results of three different data 
processing algorithms. Each data processing run will utilize a different variation of the 60 minute 
definition of accelerometer non-wear (60 consecutive minutes with zero accelerometer counts). 
The most common variations of this definition will be used, in order to assess how minor 
changes to the definition of non-wear affect real changes in reporting of activity and sedentary 
behavior for a given population. This analysis, will utilize data from adults aged 20 years and 
older in the National Health and Nutrition Examination Survey (NHANES) 2005-06 data 
collection cycle. 
6.1  BRIEF OVERVIEW OF NHANES 
Accelerometer data from the NHANES data set (2005-06 cycle) will be used to identify 
the differences in reported physical activity and sedentary behavior produced by three commonly 
used non-wear algorithms (manuscript 2). Accelerometer data from the NHANES data set (2003-
04 & 2005-06 cycles) will also be used as a p opulation representative assessment of physical 
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activity and sedentary behavior levels for comparison to the physical activity and sedentary 
behavior levels in the DPPOS study population (Manuscript 3).    
NHANES is a cross-sectional observational study of the United States population 
conducted by the National Center for Health and Statistics (NCHS) of the Centers for Disease 
Control (CDC). The NHANES survey has been conducted for nearly 50 years. Early NHANES 
assessments were conducted as a s eries of surveys that focused on different population groups 
and health outcomes. Since 1999, the survey has become a continuous program that is organized 
into 2 year cycles of data collection. The continuous NHANES survey over-samples certain 
subgroups to ensure a population representative sample and to correspond to current public 
health trends.  F rom 2003-2006 oversampling was conducted on a dolescents (12-19 years of 
age), adults > 60 years of age, African Americans, Mexican Americans, and individuals with low 
income.  
The NHANES continuous survey utilizes a multi-stage complex random survey design. 
During the first stage of sampling, primary sampling units (PSUs) are selected. These units are 
typically individual U.S. counties, but may be comprised of a group of counties. The PSUs are 
further divided into segments. Both PSUs and segments are chosen using probability 
proportional to measurement size (PPS) meaning that their probability of being included 
increases with population size. Households within each segment are selected randomly from all 
households in the segment. Individuals from selected households are chosen from random within 
designated age-sex-race/ethnicity sub-domains. Selected individuals are assigned sampling 
weights that correspond to the number of individuals that they represent in the general 
population. To ensure accurate representation of the general population, sampling weights are 
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further adjusted for non-response and other factors. Analyses that do not consider the complex 
sampling design and weights may lead to biased estimates and overstated significance. 
Household interviews are conducted on a ll selected individuals to attain demographic, 
socio-economic, dietary, and health related information. Health examinations are later conducted 
by trained clinicians and medical personnel in Mobile Examination Centers (MECs) that are sent 
to each selected PSU segment. Samples for laboratory assessments are collected during the 
examination.  
6.1.1 Measures 
6.1.1.1 Demographics 
Demographic information including age, gender, and race were collected during the 
initial screening. Age in years was self-reported at the initial screening. To ensure de-
identification, individuals over the age of 85 years were assigned the age of 85. Updated values 
for age at the time of the examination (MEC) were calculated for those individuals who were less 
than 85 years of age and did not have an imputed age value at the time of the household survey. 
Participants were asked to categorize themselves as n on-Hispanic white, non-Hispanic Black, 
Mexican American, Other Hispanic, or Other race (including mixed race). 
6.1.1.2 Physical Activity 
Physical activity measures have been included in the annual NHANES survey since 1999 
when a self-reported questionnaire was added. The questionnaire utilized in NHANES assesses 
activities of moderate and vigorous intensity performed in the last 30 days. 
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During the 2003-2004 and 2005-2006 cycles, physical activity data were collected using 
the ActiGraph AM7164 accelerometer (Pensacola, FL) which was worn at the waist and 
measured vertical acceleration.  A ccelerometry measures were collected from all eligible 
NHANES participants that were included in the mobile examination (MEC) portion of the 
survey.  Exclusionary criteria included age <6 years, walking impaired, or other limitations that 
preventing wearing the monitor according to the protocol.   
 NHANES participants were given the monitor at their MEC visit and asked to wear the 
device for the next 7 d ays, during their waking hours, and to remove the monitor for water 
related activities such as swimming or bathing.  For the data presented here, only participants 
aged 20 years or older with accelerometer data were included in the analysis of wear/ non-wear 
minutes and valid/invalid days. Additionally, the comparison of physical activity-related 
outcomes only included participants aged 20 years or older with 10 or  more hours of monitor 
wear time on at least 3 or more valid days.   
Data from the accelerometer were downloaded through the NHANES website as PAM 
files. The files were prescreened by the NCHS for outliers and unreasonable accelerometer count 
values which are flagged in the dataset.  After downloading the data, I performed all additional 
screening and processing of records with SAS code that was designed for each study. All studies 
utilized a non-wear algorithm that defined non-wear as at  least 60 consecutive minutes of zero 
counts with allowance for up to two minutes of observations greater than zero counts per minute. 
Two additional algorithms were utilized for manuscript #2.  
Average total activity counts per day were calculated using summed daily counts detected 
over wear periods. Activity intensity thresholds were defined as light, (1-2.99 METs), moderate 
(3-5.99 METs) and vigorous intensity (≥ 6METs). [A MET is an estimate of relative intensity 
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such that one MET represents the energy expenditure for an individual at rest whereas a 10 MET 
activity requires 10 times that amount]. NCI cut-point for NHANES were used in manuscript #2 
and Freedson cut-point were utilized in manuscript #3. The corresponding NCI count ranges are 
100 < = Light < 2200 < = Moderate-vigorous.  The corresponding Freedson cut-points for adults 
were light intensity (100- 1751 cts/min), moderate intensity (1752- 5724 cts/min), and vigorous 
intensity ( ≥ 5725 cts/min) activity. Time spent in sedentary behavior was defined as the amount 
of time accumulated in counts that were < 100 counts per minute. Wear time was determined by 
subtracting non-wear time from the total observation time for that day.  
6.1.1.3 Laboratory Data 
Fasting plasma glucose was assessed only on those participants in the AM session who 
were at least 12 years of age. Participants were instructed to fast for ≥ 9 hours prior to the 
laboratory procedures. Glucose concentrations were assessed by measuring the concentrations of 
nicotinanide adenine dinucleotide (NADH) spectrophotometrically at 340 mm. In additional to 
individuals who self-reported having diabetes, or use of insulin, those individuals with a fasting 
glucose level above 125 mg/dl were classified as h aving diabetes. Individuals with a f asting 
glucose level between 100 and 125 mg/dl were considered as having impaired fasting glucose, 
but not diabetes. 
6.1.1.4 Anthropometrics  
Body composition measures were also collected during the MEC portion of the survey by 
trained health technicians. Initially, weight was measured in pounds on a Toledo digital scale and 
then converted into kilograms using standard procedures. For height measurements, participants 
were asked to stand straight with their feet flat on the floor and the back of their head against a 
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vertical measurement board, aligned in the Frankfurt horizontal plane. All height measurements 
were taken in centimeters. Body Mass Index (BMI) was calculated by dividing weight in 
kilograms by height in meters squared (kg/m2). 
6.2 OVERVIEW PAPER #2 
Purpose: To determine how changes to accelerometer algorithms that differentiate 
between wearing the monitor during sedentary activities (such as sitting) versus not wearing the 
monitor, impacts on overall accelerometer results, as demonstrated in a national data set.  
Methods: 2005-06 National Health and Nutrition Examination Survey accelerometer 
data for adults, age ≥ 20 yrs. (N=4016) was processed using 3 different algorithms for 
identifying recorded periods of monitor non-wear. Each algorithm defined non-wear as a 
minimum of 60 minutes of continuous inactivity, but varied by di fferent parameters for the 
allowance of incidental movement during a non-wear period. Agreement between the results of 
the 3 algorithms for estimates of  daily average wear time, sedentary behavior, and physical 
activity outcome variables were tested using Kendall’s W correlation coefficients and by 
examining  di fferences in weighted  population mean values between each pair of algorithms; 
overall and stratified by gender, older adults (≥ 65 years) vs. all other adults, and obesity status, 
respectively. 
Results:  Kendall’s W coefficients for daily average wear time, sedentary time, and 
activity-related variables were very high between all 3 non-wear algorithms (W >.90, p<0.0001). 
Absolute mean differences between algorithms, for sedentary behavior, were clinically 
significant; ranging from 16.6-30.9 minutes/day in adults 20-64 yrs. and from 29.3-56.1 
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minutes/day in older adults. The differences in mean sedentary values between algorithms did 
not appear to vary by gender or obese status.  
Conclusion: Changing the parameters for movement allowances during monitor recorded 
non-wear time resulted in clinically significant differences in estimates of time spent sedentary, 
especially in older adults. These results argue for standardization across studies in the non-wear 
algorithms used in accelerometer processing for reporting sedentary behavior. 
 
In summary, this manuscript contributes to the overall goals of this dissertation effort by 
providing an evaluation of the algorithms used in processing physical activity and sedentary 
behavior data collected by accelerometers. This is relevant because accelerometers are the most 
widely accepted method for measuring both time spent in physical activity of all intensity levels 
and total time spent in sedentary behavior. The results of this research effort provide insight into 
the impact of small changes to accelerometer processing algorithms on reported levels of 
physical activity and sedentary behavior. The results of this effort suggest that changes to the 
definition of non-wear used in accelerometer processing algorithms can have a cl inically 
significant impact on r eported values of time spent in sedentary behaviors. Therefore, these 
results indicate that accelerometer processing algorithms developed for use with assessments of 
moderate-vigorous physical activity should also be validated for sedentary behavior. 
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7.0  PAPER #3:  PHYSICAL ACTIVITY & SEDENTARY BEHAVIOR IN THE 
         DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS) 
Objectively-measured physical activity and sedentary behavior will be reported for a 
cohort of adults with impaired glucose tolerance and type 2 diabetes mellitus, using 
accelerometer data from the Diabetes Prevention Program Outcomes Study (DPPOS). 
Additionally, to provide a context for these findings, the results from the DPPOS cohort will be 
compared to the activity and sedentary behavior levels of a representative sample of the United 
States population, from the combined National Health and Nutrition Examination Survey 
(NHANES) 2003-04 and 2005-06 data collection cycles. 
7.1 DPP AND DPPOS FOLLOW-UP STUDIES 
The Diabetes Prevention Program Outcomes Study (DPPOS) is a follow-up study of the 
original Diabetes Prevention Program (DPP) cohort. The DPPOS is designed to assess the long-
term effects of interventions used in the DPP on the development of type 2 di abetes and its 
complications. Figure 7.1 illustrates the time line and enrollment from the original DPP through 
the DPPOS and accelerometer ancillary study.  
Briefly, The DPP was a multi-center, randomized, controlled clinical trial with a primary 
aim to determine if certain interventions could prevent or delay type 2 diabetes in adults at high 
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risk for developing the disease.16 From 1996 to 1999 the study enrolled 3,234 overweight adults 
aged ≥25 years with blood glucose levels that were higher than normal but not yet in the diabetic 
range. Major exclusionary criteria included a myocardial infarction within the past 6 months, 
symptoms of coronary heart disease, serious illness, or use of medications known to impair 
glucose tolerance,  
Nearly half of all participants were from minority groups that are disproportionately 
affected by type 2 diabetes. Other higher risk groups targeted for recruitment included 
individuals age 60 and older, women with a history of gestational diabetes, and people who have 
a first-degree relative with type 2 diabetes. Study participants were randomized to a metformin 
treatment group, a lifestyle intervention group, or a placebo group. The DPP was ended after an 
average follow-up of 3.2 years.16 The results of the trial indicated that the lifestyle intervention 
reduced the incidence of diabetes by 58% (95%CI 48%, 66%) and that Metformin reduced the 
incidence of diabetes by 31% (95% CI: 17%, 43%). 
Of the 3150 eligible and surviving DPP participants, 2766 (88%) enrolled in the 
DPPOS.241 After the results of the DPP were given to the participants there was a wash-out 
period of 2 w eeks for metformin and placebo participants.  Following the wash-out period 
placebo and metformin group participants were given a 16-session group program modeled after 
the intervention given to lifestyle participants in the DPP.  
After the lifestyle intervention materials had been given to all participants the DPPOS 
follow-up study was initiated in September 2002.241 In the DPPOS, those randomly assigned to 
metformin continued taking 850 m g of the drug twice a day unless diabetes developed and 
required other types of treatment or the drug was discontinued for other reasons. However, the 
placebo pills were discontinued. All DPPOS participants were offered Lifestyle sessions (HELP) 
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every 3 months. The primary outcome remained unchanged between the DPP and DPPOS and 
outcome assessment examinations continued on the same yearly and 6 monthly schedule as in 
the DPP.  
The mean age of participants at the baseline of DPPOS was 55 years.241  68% were 
female, 55% Caucasian, 20% African-American, 16% Hispanic American, 4% Asian or Pacific 
Islander-American, and 5% American Indian.  
At the time of enrollment 38.4% of DPPOS participants had a confirmed diagnosis of 
type 2 diabetes, based on the DPP diagnostic criteria. Currently available follow-up data on the 
DPPOS indicates that after 5.5 years of follow-up in the DPPOS 1301 of the 2335 individuals 
(55.7%) with data had been diagnosed with type 2 diabetes. 241  
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Figure 7.1 Timeline & enrollment figures for the original DPP, the DPPOS follow-up study, & the 
DPPOS Accelerometer Ancillary Study 
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7.2 MEASUREMENTS IN THE DPPOS 
7.2.1 Demographics 
Demographic data on age, gender, and race/ethnicity were collected in the original DPP. 
Participants were asked to self-identify race/ethnicity as Caucasian, African-American, Hispanic 
American, Asian or Pacific Islander-American, or American Indian. 
7.2.2 Physical Activity 
Physical activity in the original DPP and the DPPOS has been measured using an 
interviewer administered recall questionnaire, the Modifiable Activity Questionnaire (MAQ). 
The MAQ assesses past year, moderate-vigorous intensity leisure and occupational activities.56 
The version of the MAQ utilized in the DPPOS population was modified to include activities 
common to the study population.242 The MAQ also assesses l eisure sedentary behavior, by 
asking participants “On average, how many hours per day do you spend watching television”. 
The MAQ is administered once a year, at the mid-year visit. 
7.2.3 Laboratory Measures 
Blood glucose levels were assessed at the midyear visit with a fasting plasma glucose test 
(FPG) and at the annual visit using an oral glucose tolerance test (OGTT). Participants were 
asked to fast for 10, but not more than 18 hours prior to their test. Testing was not performed in 
participants reporting alcohol consumption within 36 h ours prior to the test, illness within the 
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past 7 days, atypical diet in the last 3 days, steroid use, or exercise within the past 10 hours. For 
the OGTT, after a fasting blood sample is drawn participants are asked to consume a standard 
glucose containing solution of 75 gm glucose. Plasma for glucose is drawn at 0, 30, 120 minutes. 
Diabetes status is based on the ADA guidelines for blood glucose levels of ≥ 126 mg/dl FPG or ≥ 
200 mg/dl 2-h plasma glucose during an OGTT.2 Diagnosis of diabetes with either the FPG test 
or the OGTT at the clinic visit is confirmed within the 6 weeks following the initial diagnosis 
using an OGTT.   
7.2.4 Anthropometrics 
Weight was measured in pounds on a balance scale and then converted into kilograms 
using standard procedures. For height measurements, participants were asked to stand straight 
with their feet flat on the floor and the back of their head against a vertical measurement board, 
aligned in the Frankfurt horizontal plane. All height measurements were taken in centimeters. 
Body Mass Index (BMI) was calculated by dividing weight in kilograms by he ight in meters 
squared (kg/m2). 
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7.3 DPPOS ACCELEROMETER ANCILLARY STUDY 
The DPPOS Accelerometer Ancillary Study is a multi-center cross-sectional study that is 
funded by an R-01 grant through the National Institute of Diabetes and Digestive and Kidney 
Disease (NIDDK) as an ancillary study within the larger DPPOS follow-up study. The principle 
investigator of the study is Dr. Andrea Kriska, PhD of the University of Pittsburgh. This study 
was designed to incorporate an objective measure of physical activity and sedentary behavior 
into the DPPOS.   
The primary aim of the DPPOS follow-up study is the same as the original DPP. 
Therefore, neither the DPP nor the DPPOS study was designed to assess the individual effects of 
physical activity on the development of diabetes. Post-hoc analysis in the original DPP, indicated 
that leisure time moderate-vigorous activity levels reported on t he MAQ, were shown to be 
significantly different between randomized study arms, at the end of the DPP follow-up (average 
3.2 years).16 Furthermore, change in physical activity was significantly related to diabetes 
incidence, in the lifestyle arm. However, statistical significance was lost, after adjusting for 
weight change. Another post-hoc analysis within the lifestyle arm, that included an assessment of 
goal achievement and diabetes incidence, reported that for the 495 DPP lifestyle participants that 
did not meet the weight loss goal at year 1, but did meet the exercise goal, there was still a 46% 
reduction in diabetes incidence.38 
The difficulties in achieving a clear understanding of the effect of physical activity on the 
incidence of diabetes in the DPP may have been due, in part, to difference in precision between 
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the self-reported measurement of physical activity and the more precise measurement used for 
the covariate weight. Additionally, the original analysis did not consider the effects of light 
intensity physical activity or sedentary behavior, both of which have since been shown to affect 
blood glucose levels, controlling for the effects of moderate-vigorous activity.44,48  This may be 
particularly important in this population, as populations with impaired glucose tolerance and type 
2 diabetes have been shown to spent less time in moderate-vigorous activity and more time in 
light intensity activity and sedentary behavior than individuals with normal glucose 
tolerance.202,232 In relation to this, the assessment tool used in the DPPOS to measure physical 
activity levels, the MAQ, does not measure light intensity activity or total time spent sedentary. 
Therefore, in order to assess the association between all intensities of physical activity, sedentary 
behavior and the development of type 2 diabetes in the DPPOS cohort it is necessary to use an 
additional measure; the accelerometer.  
7.3.1 Study Objectives 
The primary goals of the DPPOS ancillary study are to objectively assess physical 
activity levels in the DPPOS cohort using an accelerometer to accurately measure all intensities 
of physical activity and sedentary behavior and to determine if levels of physical activity differ 
among remaining diabetic and non-diabetic participants by or iginal randomized group. 
Secondary goals include using accelerometer data to determine if those individuals who are more 
active have better health profiles. Important outcomes are factors related to diabetes and heart 
disease that are already being collected in the DPPOS. This study will also seek to determine the 
relationship between the accelerometer output and the data collected from the physical activity 
questionnaire already being used in the DPPOS (the MAQ). 
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7.3.2 Physical Activity Data Collection and Processing 
Objective physical activity data were collected using the ActiGraph GT3X accelerometer 
(Pensacola, FL).  This ActiGraph model is a small, tri-axial accelerometer that is typically worn 
at the waist. The GT3X accurately and consistently measures acceleration ranging in magnitude 
from approximately 0.05 to 2.00 Gs with frequency response of 0.25 – 2.50 Hz. This parameter 
allows for the detection of normal human motion while filtering out high-frequency vibrations 
that occur such as riding in a car.  Data are output from the ActiGraph accelerometer in the form 
of steps and activity counts, which quantify the amplitude and frequency of the filtered 
accelerations along each of the three axes. The accelerometer output is summed and outputted in 
time intervals of 1 second. For comparability to NHANES only counts from the horizontal axis 
were used in these analyses and 1 m inute averages were created from the 1 s econd output to 
match the epoch length reported for NHANES. Previous studies have demonstrated that the 
ActiGraph accelerometer is a valid and reliable measure of physical activity in adults. 
Once a p articipant signed the consent form for the accelerometer study, during their 
midyear or annual DPPOS visit, a clinic staff member initialized an accelerometer for them and 
showed the participant how to wear the monitor. All monitors were worn on a belt, at waist/hip 
height. Participants who received an accelerometer were asked to wear the monitor during 
waking hours (except during swimming or bathing) for a period of 7 days following their visit. 
Participants were asked to record the time at which they put on the monitors and the time they 
took off the monitors in a physical activity (PA) diary.  At the end of the 7 da y period, the 
participant returned the accelerometer and PA diary by r eturning the monitor in person or 
mailing it back to the clinic.  
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Data was then downloaded by the clinic staff onto a local, designated computer(s) using 
software provided by ActiGraph, the makers of the GT3X accelerometer. The data was 
transferred to the University of Pittsburgh Accelerometer Data Coordinating Center from the 
clinics via a p roprietary data transfer system, known as d ata stream, designed by the 
Epidemiology Data Center (EDC) at the University of Pittsburgh. Data stream was loaded on all 
designated computers, at each site and was set to run automatically each day. In addition to 
transferring all files, the data stream program also created an archive of the transferred files on 
the local computer and notified a designated staff member via email, as to which files had been 
sent and received by the data coordinating center.   
Data from the accelerometers were processed, and screened for wear time. Non-wear was 
defined as at least 60 consecutive minutes of zero counts with allowance for up to two minutes of 
observations greater than zero counts per minute. Wear time was determined by subtracting non-
wear time from the total observation time for that day. Participants must have had accelerometer 
data that included 10 h ours of wear time on 4 or  more valid days to be included in the final 
analyses.68 Only days with 10 or more hours of wear time were utilized to calculate mean daily 
physical activity and sedentary behavior. 
 Average total activity counts per day were calculated using summed daily counts 
detected over wear periods for counts recorded on the horizontal axis. The sum of the activity 
counts were then related to activity intensity and categorized based on validated activity count 
cut-points. Time in minutes spent in different activity intensities were calculated using count 
ranges corresponding to sedentary, light (1-2.99 METs), moderate (3-5.99 METs) and vigorous 
(≥ 6 METs) intensity activity. [A MET is an estimate of relative intensity such that one MET 
represents the energy expenditure for an individual at rest whereas a 10 MET activity requires 10 
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times that amount].  F reedson cut-points for adults corresponding to sedentary behavior (0-99 
cts/min), light intensity (100-1751 cts/min), moderate intensity (1752-5724 cts/min), and 
vigorous intensity ( ≥ 5725 cts/min) activity were used.131  
7.3.3 Eligibility and Recruitment 
Twenty-three of the remaining 26 DPP sites agreed to participate in the accelerometer 
study. All remaining DPPOS participants at contributing sites, that were not confined to a 
wheelchair and able to walk, were eligible for study inclusion. Participation in the ancillary study 
was optional and all recruitment, consent, and enrolling of participants was conducted by clinic 
staff at each site. I conducted all recruitment, consenting, and enrollment of participants at the 
Pittsburgh site. Enrollment was conducted from October 2010 to June 2012. A total of 1794 
participants from 23 sites were enrolled in the Accelerometer Ancillary Study (Figure 7.1).  
7.3.4 Enrollment and Retention 
At the beginning of the enrollment period for the accelerometer ancillary study there 
were 2542 DPPOS participants from all 26 sites across the United States (Figure 7.2). In this 
cohort, an estimated 1932 pa rticipants were actively attending scheduled clinic visits at sites 
participating in the accelerometer ancillary study. Overall, 1794 ( 92.8%) of the active 
participants at enrolled sites consented to participate in the accelerometer study. Of the 138 
participants not consented, 9 w ere ineligible due to either cognitive impaired or because they 
were non-ambulatory and the remaining 131 either declined to participate or did not come in for 
a clinic visit during the enrollment period.  
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 Figure 7.2 Enrollment and retention of DPPOS Accelerometer ancillary study participants 
 
Seventeen hundred and fifty-seven of the 1794 participants (97.9%) that enrolled in the 
study had at least one valid day of 10 or more hours of wear time and were issued a results letter 
(Figure 7.2). The letters contained the participant’s personal values for moderate-vigorous 
intensity activity, light intensity activity, total activity (light + moderate-vigorous activity), and 
sedentary time in both minutes and hours per day, as well as, comparison values from the 
combined NHANES 2003-04 and 2005-06 study cohorts. Of the participants with ≥1 valid day, 
1609 (91.5% of enrolled participants) met the requirement of at least 4 da ys of valid monitor 
wear and were therefore included in all final analyses of activity-related outcome variables.  
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7.3.5 Participant Characteristics 
Demographic data for the 1609 individuals included in the final analyses is presented in 
table 7.1. At the time the study was conducted, the 1794 participants who enrolled in the 
Accelerometer Ancillary Study had a mean age of 63.67 ye ars and 69.57% were female. The 
cohort was 52.5% Caucasian, 18% African-American, 17% Hispanic American, 5% Asian or 
Pacific Islander-American, and 7% American Indian (table 7.1). There were no significant 
demographic or randomization differences between the subpopulation of individuals that 
completed 4 or more days and those individuals that did not. (p < 0.05 for all variables) 
 
Table 7.1 Basic demographic variables and randomized arm assignment for all individuals enrolled in the 
DPPOS accelerometer study and for those individuals with at least 4 valid days of recorded wear time.  
 
 
 
 
 
 
 
 
 
 
 
 
 All Enrolled 
Participants 
Participants with 4 or 
more valid days 
 N= 1794 N=1609 
Mean Age 63.67 (SEM 0.26) 63.69 (SEM 0.24) 
Gender 69.57 % female 69.86 % female 
Race   
         Caucasian 52.5 % 53 % 
         African-American 18 % 18 % 
         Hispanic-American 17 % 17 % 
         Asian or Pacific 
         Islander- American 
5 % 5 % 
         American Indian 7 % 7 % 
         Not given .05 % <.05 % 
Randomized arm   
         DPP Placebo 33.67 % 33.81 % 
         DPP Lifestyle 33 % 32.75 % 
         DPP Metformin 33.33 % 33.44 % 
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7.4 PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOR LEVELS IN THE 
DPPOS COHORT 
7.4.1 Statistical analyses 
Descriptive statistics for accelerometer data are provided for all DPPOS participants with 
≥ 4 valid days (10+ hours of wear time) of recording. Statistical comparisons using ANCOVA 
were performed to determine the effect of age, gender, race/ethnicity, and treatment group on 
reported values of physical activity and sedentary behavior, controlling for the effects of the 
other covariates, as well as, wear time. Adjusted least-square means are presented for time spent 
sedentary and in light, moderate-vigorous (MVPA) and total (TPA) physical activity to provide a 
less biased assessment of differences in sedentary behavior and physical activity between 
important population sub-groups. Age was included as a continuous variable in all models. 
However, additional models with age as a categorical variable (39-59, 60-69, and ≥ 70 years of 
age) were run, so that adjusted least-square means could be produced for categories of age.   
7.4.2 Unadjusted estimates of physical activity and sedentary behavior 
Unadjusted descriptive data for the 1609 D PPOS participants who completed the 
accelerometer study with ≥ 4 valid days of data is provided in table 7.2.  Mean accelerometer 
wear time was 841.85 (SEM 2.06) minutes or about 14 hours per day. On average participants 
spent 556.27 (SEM 2.17) minutes per day (9.25 hours/day) in sedentary behaviors. Additionally, 
285.57 (SEM 2.25) minutes per day (4.75 hrs./day), on average, were spent in total (light and 
moderate-vigorous intensity) physical activity. Specifically, an average of 15.33 (SEM 0.48) of 
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the total activity minutes were spent in moderate-vigorous physical activity (MVPA). The 
median estimate for time spent in MVPA was 8.50 minutes/day.  
 
  Table 7.2 Unadjusted descriptive statistics for activity-related variables for the 1609 DPPOS 
participants with at least 4 valid days of wear time. 
 
 
7.4.3 Identification of important covariates for physical activity and sedentary behavior 
levels in the DPPOS  
Comparisons of values for wear time based on Mann Whitney-U statistics (not shown) 
indicated that wear time was significantly different (P<0.05) across treatment, gender, age, and 
race/ethnicity groups. ANCOVA analysis was then performed, to examine differences between 
mean values of sedentary time, time spent in light intensity, moderate-vigorous intensity, and 
total physical activity, across treatment arm, age, gender, and racial/ethnic groups.  S everal 
stages of model building were performed. The fully adjusted model contained data from 1605 of 
Activity-related variable 
Mean (SEM) Median 
Lower 
Quartile 
Upper 
Quartile 
Range 
Sedentary (min/day  0-99 ct)  
Light activity (min/day 100-1951 ct) 
Moderate-vigorous activity 
 (min/day >=1952 ct) 
Total activity (Light + MVPA) 
Count avg (ct/min/d) 
Count total (per day) 
Estimated Wear time (min/day) 
 
556.27 (2.17) 
270.24 (2.10) 
15.33 (0.48) 
 
285.57 (2.25) 
250.81 (20.11) 
210909 (15901) 
841.85 (2.06) 
 
557.71 
257.86 
8.50 
 
273.86 
199.98 
169138 
841.67 
 
500.86 
210.83 
2.67 
 
223.14 
149.53 
121278 
780.60 
 
612.60 
321.67 
20.86 
 
342.17 
274.21 
238834 
897.71 
 
717.43 
584.54 
246.00 
 
605.73 
26751 
22108716 
608.68 
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the total 1609 i ndividuals; due to missing race/ethnicity information on 4 pa rticipants. All 
models included wear time and treatment group. Only the models for moderate-vigorous 
physical activity violate the assumptions of homoscedasticity (equal variance) and normality 
(data not shown). As a result, moderate-vigorous physical activity was transformed using the 
square root transformation. 
For sedentary behavior, light intensity, and total physical activity there was a significant 
interaction between treatment group and average wear time, therefore the interaction term was 
included in the models for these outcome variables, but not moderate-vigorous physical activity. 
Based on the ANCOVA results, there were significant differences for sedentary, light intensity, 
and total physical activity (P< 0.05) across treatment groups in the model that controlled for 
treatment group and wear time only. Additionally, differences between age, gender, and 
race/ethnicity groups were also significant for all sedentary and physical activity variables 
(ANCOVA P< 0.05) when these variables were each independently added, as covariates, to the 
model that contained treatment group, average wear time, and the interaction term. There were 
no other first order interaction terms. 
However, when all demographic variables were added to the model together treatment 
group was no longer significant in any of the full models. Additionally, the difference between 
gender groups was no longer significant in the full model for sedentary behavior.  
7.4.4 Adjusted least square means for time spent in physical activity and sedentary 
behavior among DPPOS participants  
Tables 7.3- 7.6 contain adjusted least square mean values for minutes per day of 
sedentary behavior, light intensity, square root transformed moderate-vigorous, and total 
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physical activity for treatment  group (table 7.3), gender (table 7.4), age group (table 7.5) and 
racial/ethnic group (table 7.6); adjusted for important covariates.   
Overall, the differences between treatment groups in total physical activity were small 
(differences in adjusted mean values <10 minutes/day) and insignificant with a slightly lower  
adjusted mean value for sedentary behavior and slightly higher mean values for light intensity 
and transformed moderate-vigorous intensity physical activity in the DPP lifestyle group when 
compared to the metformin and placebo groups (table 7.3).  
 
 
Table 7.3 Adjusted least-square means (95% CI) by treatment group for time (minutes/day) spent in 
different intensities of physical activity and sedentary behavior.1  
 
Activity Variable 
DPP Placebo 
N=542 
DPP Lifestyle 
N=526 
DPP Metformin 
N=537 
Sedentary (min/day  0-99 ct) 
555.78 
(548.32, 563.24) 
551.13 
(543.64, 558.621) 
556.05 
(548.47, 563.64) 
Light PA (min/day 100-1951 ct) 
268.83 
(261.83, 275.83) 
272.19 
(265.16, 279.22) 
268.78 
(261.66, 275.90) 
SQRT  Moderate-vigorous (MV) 
PA (min/day >=1952 ct) 
3.51                      
(3.33, 3.70) 
3.72                    
(3.53, 3.91) 
3.54                       
(3.35, 3.73) 
Total PA (Light + MV PA) 
min/day 
286.12             
(278.66, 293.58) 
290.77             
(283.28, 298.26) 
285.85              
(278.26, 293.43) 
PA= Physical activity  ,   * Significantly different than reference group: DPP Placebo, P<.05 
 
 
                                                 
1 All values are adjusted for average wear time, age, race/ethnicity, and gender. Sedentary behavior and 
light activity are adjusted for treatment group*average wear time. 
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The adjusted mean value for light intensity physical activity (table 7.04) was significantly 
higher in females when compared to males (275.51 versus 264.36 minutes/day, p=0.005). 
Conversely, the adjusted mean value for the square root of moderate-vigorous physical activity 
was lower in females when compared to males (p< 0.001) Overall, differences in sedentary time 
and total physical activity between males and females was small and insignificant. 
 
 
 
Table 7.4 Adjusted least-square means (95% CI) by gender for time (minutes/day) spent in different 
intensities of physical activity and sedentary behavior. 2  
 
Activity Variable 
Female 
N=1121 
Male 
N=484 
Sedentary (min/day  0-99 ct) 
552.99 
(547.25, 558.73) 
555.65 
(547.91, 5563.39) 
Light PA (min/day 100-1951 ct) 
275.51* 
(270.12, 280.90) 
264.36 
(257.09, 271.63) 
SQRT  Moderate-vigorous (MV) PA 
(min/day >=1952 ct) 
3.07*                        
(2.93, 3.21) 
4.11                      
(3.92, 4.30) 
Total PA (Light + MV PA) min/day 
288.91                   
(283.17, 294.65) 
286.25                  
(278.50, 293.99) 
       PA= Physical activity , SQRT= square root,    
       * Significantly different than reference group: Males, P<.05 
 
 
 
 
                                                 
2 All values are adjusted for average wear time, age, race/ethnicity, and gender. Sedentary behavior and 
light activity are adjusted for treatment group*average wear time. 
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In general, adjusted mean sedentary time increased with age while both light intensity 
and moderate-vigorous intensity physical activity decreased, as age increased (table 7.5). 
Differences in adjusted mean values for sedentary and light intensity activity were significantly 
different (P< 0.0001) in all age groups, when compared to the youngest age group (39-59 years). 
As age increased accelerometer measured sedentary behavior increased and all intensities of 
physical activity decreased. 
 
 
Table 7.5 Adjusted least-square means (95% CI) by age group for time (minutes/day) spent in 
different intensities of physical activity and sedentary behavior.3  
 
Activity variable 
 
39-59 years 
N=569 
 
60-69 years 
N=606 
 
70+ years 
N=434 
Sedentary (min/day  0-99 ct) 
541.55              
(534.03, 5449.07) 
549.04* 
(541.82, 556.25) 
576.67* 
(568.32, 585.02) 
Light PA (min/day 100-1951 ct) 
278.81 
(271.75, 285.86) 
274.71* 
(267.95, 281.47) 
252.97*           
(245.14, 260.80) 
SQRT  Moderate-vigorous (MV) 
PA (min/day >=1952 ct) 
4.19                      
(4.00, 4.38) 
3.67*                      
(3.48, 3.85) 
2.77*                   
(2.56, 2.98) 
Total PA (Light + MV PA) 
min/day 
300.35               
(292.82, 307.87) 
292.86*              
(285.65, 300.07) 
265.23*           
(256.88, 273.58) 
          PA= Physical activity, SQRT= square root,   
          * Significantly different than reference group: 39-59 years, P< .05 
 
 
 
                                                 
3 All values are adjusted for average wear time, treatment group, gender, and race/ethnicity. 
Sedentary behavior and light activity are adjusted for treatment group*average wear time. 
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Comparisons across racial/ethnic groups (table 7.6) revealed greater similarities between 
the Black non-Hispanic, white non-Hispanic, and Asian or Pacific Islander non-Hispanic groups 
for sedentary behavior and light intensity physical activity, with greater departures in values for 
the Hispanic and Native American groups. 
Adjusted mean values for sedentary time were significantly lower for Hispanics (529.02 
minutes/day, p<0.0001) and Native Americans (546.60 minutes/day, p=0.04) when compared to 
White non-Hispanics (563.10 minutes/day). 
 
 
Table 7.6 Adjusted least-square means (95% CI) by race/ethnicity for time (minutes/day) spent in 
different intensities of physical activity and sedentary behavior.4  
 
      PA= Physical activity , SQRT= square root,     * Significantly different than reference group: White, P<.05 
                                                 
4 All values are adjusted for average wear time, treatment group, gender, and age group. Sedentary behavior 
and light activity are adjusted for treatment group*average wear time. 
 
Activity variable 
Asian 
N=83 
Black 
N=285 
Hispanic 
N=275 
Native 
American 
N=109 
White 
N=853 
Sedentary (min/day  0-99 ct) 
564.41   
(548.02,580.79) 
568.47     
(559.41, 577.54) 
529.02*      
(519.94, 538.10) 
546.60*      
(531.90, 561.30) 
563.10        
(557.79, 568.43) 
Light PA                      
(min/day 100-1951 ct) 255.04   
(239.66,270.41) 
259.49     
(250.98, 268.00) 
294.10*      
(285.57, 302.62) 
279.28*      
(265.48, 293.08) 
261.77        
(256.77, 266.77) 
SQRT  Moderate-vigorous 
(MV) PA (min/day >=1952 ct) 4.17*             
(3.76, 4.59) 
3.14 *            
(2.92, 3.37) 
3.80*                
(3.57, 4.03) 
3.33                
(2.96, 3.70) 
3.51                
(3.37, 3.64) 
Total PA (Light + MV PA) 
min/day 277.49      
(261.11, 293.88) 
273.42     
(264.35, 282.49) 
312.88*        
(303.79, 321.96) 
295.30*        
(280.60, 310.00) 
278.80        
(273.47, 284.12) 
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For light intensity physical activity adjusted mean values were significantly higher for Hispanics 
(294.10 minutes/day, p<0.0001) and Native Americans (279.28 minutes/day, p= 0.02) when 
compared to White non-Hispanics (261.77 minutes/day). For the square root of moderate-
vigorous physical activity adjusted mean values for Asian or Pacific Islander non-Hispanics and 
Hispanics were significantly higher compared to non-Hispanic whites (p=0.003 and p=0.03, 
respectively); while the adjusted mean values for Native Americans and Black non-Hispanics 
were lower (p=0.37  and p=0.006, respectively).  
7.4.5 Summary 
Overall, when examining potential covariates, the largest differences between groups 
appeared to be across categories of age with increasing amounts of sedentary behavior and 
decreasing amounts of light and moderate-vigorous physical activity as age category increased. 
As a w hole, there were also significant differences in adjusted means between racial/ethnic 
groups in the fully adjusted model for all activity-related outcome variables. Likewise, 
differences in gender were also significant for specific intensities of physical activity in the fully 
adjusted model, but not for total physical activity or sedentary behavior. Finally, although there 
were small differences between treatment groups in mean time spent sedentary and mean time 
spent in different intensities of physical activity, these differences were not statistically 
significant after controlling for the effects of age, gender, race/ethnicity, and wear time. 
Therefore, comparisons between the physical activity and sedentary behavior levels in the 
 80 
DPPOS and NHANES populations should consider age and, if possible, gender and 
race/ethnicity in the research design, as important covariates. 
7.5 NHANES 2003-06 COMPARISON POPULATION 
To provide a basis for drawing conclusions about the physical activity and sedentary 
behavior levels reported from the DPPOS cohort, this effort compared the DPPOS cohort and a 
population representative cohort of similar aged adults. The National Health and Nutrition 
Examination Survey Population (NHANES) from 2003-04 and 2005-06 was chosen as t he 
comparison population for two major reasons. First of all, when weighting procedures are 
properly used, NHANES provides a large population representative sample for comparison. 
Secondly, accelerometer data, from the ActiGraph accelerometers that were used to collect data 
on physical activity and sedentary behavior in NHANES from 2003-2006, has been previously 
shown to be comparable to the data collected from the newer generations of ActiGraph GT3X 
accelerometers used in the DPPOS cohort; provided that the results from both accelerometer 
models are based on one axis (the vertical axis).243,244 
7.5.1 Statistical analyses for NHANES descriptive statistics 
To comply with the 10 year age categories utilized in the sampling design of NHANES, 
individuals that were 39 years of age or younger were not included from the NHANES datasets. 
Therefore, all presented NHANES data is for individuals aged ≥ 40 years who participated in the 
accelerometer study and had  ≥ 4 days of 10 or more hours of wear time. Calculations of means 
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and standard errors for NHANES data were performed utilizing weighting procedures, based on 
the complex sampling design. Reweighting of the population was done to adjust for unequal 
probabilities of selection and non-response prior to the analysis of accelerometer data and 
utilized modified code provided by NCI (National Cancer Institute) for NHANES. Data for both 
the 2003-04 and 2005-06 cycles were reweighted for age, gender, race/ethnicity, and BMI.  
For the sub-sample of individuals from NHANES 2003-04 and 2005-06 that provided 
fasting blood samples for the fasting plasma glucose (FPG) test; the sampling weights provided 
for the fasting subsample by the CDC were used instead of the examination weights. Likewise, 
for the smaller sample of fasting participants that completed an oral glucose tolerance test 
(OGTT) the sampling weights provided for the OGTT subsample were used instead of the 
examination weights. The same reweighting procedures were used in both of these sub-samples. 
Fasting sub-sample weights were also converted to a four year data set (4 year weights). Because 
the OGTT was only given in the 2005-2006 cycle; 2 year weights were utilized. 
Diabetes status was determined on the basis of glucose tolerance and included categories 
of normal glucose tolerance, impaired glucose tolerance, and diabetes mellitus. For the fasting 
subsample participants, diabetes status was determined on the basis of reported diabetes 
medication usage and the results of the FPG test. For the OGTT subsample participants, diabetes 
status was determined on the basis of reported diabetes medication usage and the results of the 
oral glucose tolerance test (OGTT). Identification of impaired glucose tolerance and diabetes 
mellitus for the FPG and OGTT tests were made in accordance with the ADA guidelines.2 
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7.5.2 NHANES participant characteristics 
A total of 4376 adults age ≥ 40 years, in the general NHANES 2003-04 and 2005-06 
combined cohort, had at least 4 days with ≥ 10 hours of monitor wear time. 1839 of these 
individuals were also randomly selected to participate in the morning blood draw and therefore 
were included in the fasting subsample. 654 of those 1839 individuals in the fasting subsample 
were also selected to participate in the oral glucose tolerance test (OGTT subsample).  
Population weighted estimates for age, gender, race/ethnicity, and diabetes status are 
provided in table 7.7. The weighted mean (SEM) age of participants was 56.9 (0.43), 57.3 (0.45), 
and 56.9 ( 0.73) years for all individuals, the fasting subsample, and the OGTT subsample 
participants, respectively. Between 76% and 78% of individuals in each subgroup self-identified 
as non-Hispanic White and close to 53% were female. Differences in the weighted demographic 
variables across the three groups (all participants, fasting subsample participants, and OGTT 
subsample participants) were small, as w as expected, due to the weighting and reweighting 
procedures used for each population subgroup.  
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Table 7.7 Population weighted demographic data for participants  age ≥40 years, with 4+ valid days 
of accelerometer data from NHANES 2003-06. 
 
OGTT= oral glucose tolerance test       SEM= standard error of the mean      NA=Not available  
* weighted values based on those individuals that participated in the fasting tests for 2003-04 & 2005-06.  
** weighted values based on  participants that took part in the oral glucose tolerance test (given only in 2005-06) 
 
  
 All 
Participants 
N= 4376 
Fasting sample 
participants 
N= 1839* 
OGTT sample 
participants 
N= 654** 
Mean( SEM)  age 56.9 (0.43) 57.3 ( 0.45) 56.9 ( 0.73) 
Gender (female) 52.6 %  53.3%  52.8 %  
Race/ethnicity    
 Mexican American 5.8 % 6.1 % 5.5 % 
 Other Hispanic 2.7 % 2.0 % 2.4 % 
 White, non-Hispanic 76.7 % 76.8 % 77.7 % 
  Black, non-Hispanic 10.4 % 10.0 % 9.3% 
  Other (including 
      mixed race) 
4.4 % 5.2 % 5.0 % 
Diabetes status    
Normal glucose tolerance NA 48.8 % 70 % 
Impaired glucose tolerance NA 34.8 % 20 % 
Diabetes NA 16.4 % 10 % 
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Additionally, the results on table 7.7 indicate that a higher percentage of individuals were 
identified as having diabetes in the fasting subsample group when compared to the OGTT 
subsample group (16.4% versus 10%).  L ikewise, a higher percentage of individuals in the 
fasting subsample were reported to have impaired glucose tolerance when compared to 
individuals in the OGTT subsample (34.8% versus 20%).   I t is unclear if this difference is the 
result of differences in population sampling or if it is the result of differences in the identification 
test used for diabetes status; since the FPG test was used as the primary identification tool for the 
fasting subsample and the oral glucose tolerance test was used as the primary identification tool 
for the OGTT subsample. 
Therefore, to determine if the differences in diabetes status between the OGTT subsample 
and the fasting subsample may have resulted from the differential identification of diabetes and 
impaired glucose tolerance, by the FPG test and the oral glucose tolerance test (OGTT), a more 
detailed comparison of the FPG and OGTT results was conducted in the subsample of 
individuals that completed both the FPG and OGTT. Agreement between the results of the FPG 
and OGTT tests for the identification of impaired glucose tolerance and diabetes mellitus was 
assessed via a sensitivity/specificity analysis for results from the FPG when compared to the gold 
standard, the OGTT. Additionally, descriptive comparisons were made between the mean values 
for time spent in physical activity and sedentary behavior for the fasting subsample and OGTT 
subsample participants to examine if differences between other population characteristics of the 
subsamples resulted in differences in accelerometer reported physical activity or sedentary 
behavior. 
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7.5.3 Comparison of diabetes status classification between the oral glucose tolerance test 
and fasting plasma glucose 
654 Individuals aged ≥ 40 years from the 2005-06 cycle of NHANES completed both the 
FPG and the OGTT. Diabetes status was determined according to the ADA guidelines for both 
the FPG and OGTT.2 The 45 Individuals who report taking diabetes medications at the time of 
the examination and blood draw were not included in the comparison of results between the two 
measures. Table 7.8 contains the sensitivity, specificity, positive predictive value (PPV), and 
negative predictive value (NPV) for the FPG when compared to the gold standard measure, the 
OGTT, based on population weighted estimates (using the fasting subsample weights) from the 
remaining 609 individuals.  
The sensitivity and specificity can be defined as the proportion of actual positives which 
are correctly identified and the proportion of actual negatives which are correctly identified, 
respectively. Additionally, the PPV and the NPV can be thought of as the ratio of true positives 
to combined true and false positives and the ratio of true negatives to combined true and false 
negatives, respectively. 
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Table 7.8 Sensitivity, specificity, PPV, and NPV for the identification of impaired glucose tolerance 
and type 2 d iabetes mellitus, by fasting plasma glucose (FPG); when compared to results from the oral 
glucose tolerance test (OGTT).5 
 
 Sensitivity Specificity PPV NPV 
Type 2 diabetes 
mellitus 
47.64 99.93 98.68 94.66 
Impaired glucose 
tolerance 
58.43 71.44 25.88 90.96 
Impaired glucose 
tolerance & type 2 
diabetes mellitus 
74.60 63.43 45.77 85.78 
PPV= positive predictive value,   NPV= negative predictive value  
 
 
For the diagnosis of type 2 diabetes the FPG was very good at identifying those that did 
not have diabetes (specificity 99.93 and NPV 94.66). Additionally, more than 98% of the 
diabetes cases identified in this population by the FPG were confirmed by the OGTT. However, 
more than 50% of true diabetes cases were missed by the FPG (sensitivity 47.64). 
The OGTT confirmed negative findings for impaired glucose tolerance from the FPG test 
more than 90% of the time and the FPG test identified a fair proportion of all true impaired 
glucose tolerance cases (71.44%). Conversely, only about 25% of the cases of impaired glucose 
                                                 
5 Results are based on population weighted values from the 609 individuals from NHANES 2005-06, aged ≥40 
years, with 4+ days of accelerometer data, not taking diabetes medication w/ both OGTT and FPG results. ADA 
criteria for the FPG and OGTT results were used to identify impaired glucose tolerance and type 2 diabetes mellitus. 
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tolerance identified by the FPG test were confirmed positive by the OGTT and the FPG test only 
identified about 58% of the true impaired glucose tolerance cases. Although the sensitivity and 
specificity of the FPG test has been shown to vary across populations, the results of this analysis 
are in line with the results of other studies that reported sensitivity and specificity values for the 
FPG (compared to the OGTT) from adult populations in the United States,245 Europe,246 and 
Korea.247  
These results suggest that there are important differences between the FPG and the 
OGTT for identifying individuals as having impaired glucose tolerance and diabetes.  Therefore, 
when the results for activity outcomes from NHANES are examined by diabetes status groups (in 
addition to age and gender) it will be important to report findings from both the OGTT 
subsample and the larger fasting subsample for mean values of physical activity and sedentary 
behavior. This will be particularly important if the differences are large enough to affect the 
interpretation of comparisons between the NHANES and DPPOS cohorts.  
 
7.5.3 Physical activity and sedentary behavior levels for individuals in the fasting 
subsample and for individuals in the OGTT subsample 
Descriptive statistics, based on popul ation weighted estimates for average wear time, 
sedentary behavior, light intensity, moderate-vigorous intensity, and total physical activity (light 
+ moderate-vigorous intensity) in minutes/day are presented in table 7.9 f or the fasting 
subsample and in table 7.10 for the OGTT subsample. Population weighted estimates for average 
total counts/ day and average counts/minute are also presented.  
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Table 7.9 Descriptive statistics based on population weighted estimates of activity-related variables 
for individuals aged ≥40 years in the NHANES 2003-06 fasting sample group. 6  
 
 
On average, NHANES 2003-06 participants in the fasting subgroup, who were age ≥40 
years and had at least 4 valid days (≥10 hours of wear time), had an average monitor wear time 
of 858.93 minutes or about 14.3 hours/ day. Additionally, on a verage these participants spent 
503.99 (SEM 3.02) minutes/day (8.39 hours/day) in sedentary behavior and 354.94 (SEM 3.03) 
minutes/day (5.91 hours/day) in total physical activity.  On average, 21.25 (SEM 0.81) 
minutes/day of their total physical activity was spent in moderate-vigorous intensity activities. 
 
 
 
                                                 
6 with at least 4 valid days of accelerometer wear time. 
Activity-related variable 
Mean (SEM) Median 
Lower 
Quartile 
Upper 
Quartile 
Range 
Sedentary (min/day  0-99 ct)  
Light activity (min/day 100-1951 ct) 
Moderate-vigorous activity 
 (min/day >=1952 ct) 
Total activity (Light + MVPA) 
Count avg (ct/min/d) 
Count total (per day) 
Estimated Wear time (min/day) 
 
503.99 (3.02) 
333.68 (2.68) 
21.25 (0.81) 
 
354.94 (3.03) 
291.10 (4.93) 
249659 (4513.18) 
858.93 (3.05) 
 
495.60 
329.78 
14.79 
 
349.26 
269.63 
231265 
848.47 
 
421.47 
261.22 
4.69 
 
278.02 
187.20 
156078 
789.65 
 
579.71 
401.33 
31.04 
 
430.00 
369.39 
315862 
907.60 
 
1039.82 
725.36 
206.40 
 
745.02 
1146.40 
966574 
769.63 
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Mean values for daily sedentary behavior and physical activity variables appear to be 
similar between the fasting subsample (table 7.9) and the smaller OGTT subsample (table 7.10). 
On average, NHANES 2005-06 participants in the OGTT subgroup, who were age ≥40 years and 
had at least 4 va lid days, spent 501.79 (SEM 5.09) minutes/day (8.36 hours/day) in sedentary 
behavior and 362.48 (SEM 5.66) minutes/day (6.04 hours/day) in total physical activity (Table 
7.10).  On average, 22.38 (SEM 1.38) minutes/day of their total physical activity was spent in 
moderate-vigorous intensity activities. 
 
 
 
Table 7.10 Descriptive statistics based on population weighted estimates of activity-related variables 
for individuals aged ≥40 years in the NHANES 2005-06 OGTT sub-sample. 7 
 
 
 
 
 
                                                 
7 with at least 4 valid days of accelerometer wear time. 
Activity-related variable 
Mean (SEM) Median 
Lower 
Quartile 
Upper 
Quartile 
Range 
Sedentary (min/day  0-99 ct)  
Light activity (min/day 100-1951 ct) 
Moderate-vigorous activity 
 (min/day >=1952 ct) 
Total activity (Light + MVPA) 
Count avg (ct/min/d) 
Count total (per day) 
Estimated Wear time (min/day) 
 
501.79 (5.99) 
340.10 (5.17) 
22.38 (1.38) 
 
362.48 (5.66) 
301.18 (8.53) 
259483 (7508.03) 
864.27 (5.09) 
 
494.42 
338.75 
15.73 
 
355.87 
274.58 
238647 
850.53 
 
413.14 
264.77 
5.43 
 
281.84 
196.63 
165808 
793.98 
 
588.90 
410.40 
32.54 
 
439.05 
386.85 
332233 
915.15 
 
973.07 
719.02 
180.67 
 
740.86 
1146.40 
301.18 
769.63 
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Based on these results, there is no evidence of population level differences between the 
2005-06 NHANES OGTT subsample and the 2003-04 and 2005-06 fasting subsample that may 
cause differences between the values reported for physical activity and sedentary behavior 
related outcome variables from the two subsamples. Therefore, no additional examination for the 
differences in population characteristics between the two subsamples was warranted.  
7.5.4 Summary 
There were no important differences in mean daily values for physical activity and 
sedentary behavior related variables between the NHANES 2005-06 OGTT subsample and the 
NHANES 2003-04 and 2005-06 combined fasting subsample. Therefore, it was decided to use 
only the larger fasting subsample for comparisons between the DPPOS cohort and the NHANES 
population when stratifying only by ge nder and age. However, the results of the 
sensitivity/specificity analysis and the small sample size of the OGTT subsample support 
including estimates of time spent in physical activity and sedentary behaviors from both the 
NHANES 2005-06 OGTT subsample and the NHANES 2003-06 fasting subsample for 
comparisons that are stratified by diabetes status. In this way, the larger fasting subsample can be 
used for the primary comparisons and the OGTT subsample, which uses a better method for 
assigning diabetes status, can be used to confirm the findings of the comparisons between the 
DPPOS cohort and the NHANES fasting subsample (when there are enough OGTT subsample 
participants to do so).  
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7.6 COMPARISON OF PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOUR 
BETWEEN DPPOS AND NHANES PARTICIPANTS 
The results of previous studies suggest that glucose levels are related to higher levels of 
sedentary behavior and lower levels of physical activity.39,40,44,45,209 Therefore, it would be 
expected that physical activity levels would be lower and sedentary behavior levels would be 
higher in the DPPOS cohort, when compared to a nationally representative sample of similar age 
and gender adults from the NHANES cohort. This is based on the fact that all individuals in the 
DPPOS cohort have been identified as having impaired glucose tolerance or type 2 di abetes 
compared to the NHANES fasting subsample in which nearly half of all individuals included in 
the comparison population had normal glucose tolerance at the time of the activity monitoring 
and blood draw (48.8% of those w/ ≥ 4 valid days of wear time).   
Based on the same premise, for the comparisons that include diabetes status, it would be 
expected that the physical activity and sedentary behavior levels in the DPPOS cohort would be 
similar to individuals with diabetes and impaired glucose tolerance in NHANES. More 
specifically, because a previous DPPOS report 241 indicated that several years prior to this 
current data collection effort, more than half of all DPPOS participants had been diagnosed with 
diabetes, it would be expected that participants in the DPPOS would have physical activity and 
sedentary behavior levels more similar to individuals with diabetes in NHANES or at least in 
between those individuals with impaired glucose tolerance and those individuals with diabetes 
from NHANES.    
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7.6.1 Statistical analyses 
Descriptive comparisons of DPPOS data to NHANES data were stratified by important 
covariates that were determined from the results of the ANCOVA analysis for the DPPOS 
population. Comparisons between the DPPOS population and similar aged individuals in the 
NHANES 2003-06 data set were performed using those NHANES 2003-06 adults, age ≥ 40 
years with 4 or more valid days of monitoring, whose diabetes status was determined on the 
basis of the FPG test results (fasting subsample) and separately for the subgroup of individuals 
whose diabetes status was determined on the basis of the OGTT (OGTT subsample). Tests of 
trend across diabetes status groups for differences in sedentary behavior, light and moderate-
vigorous intensity physical activity were performed for the NHANES fasting subsample using 
the Wald F test statistic generated from generalized ordinal logistic models. Wear time was 
tested as a potential covariate in all models. All models were stratified by gender and age 
category. Subgroups represented by less than 15 people were not included in the final 
assessments due to the potential loss of population representativeness and tests of trend were not 
performed on the OGTT subsample due to low numbers of individuals with diabetes in most 
age/gender subgroups. 
Statistical analyses were performed using SAS 9.3 with the exception of the generalized 
ordinal logistic regression models and the assessment of trend for differences in time spent in 
physical activity and sedentary behavior by di abetes status group; which was performed in 
StataSE12. 
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7.6.2 Descriptive comparisons of DPPOS and NHANES physical activity and sedentary 
behavior levels stratified by age and gender 
Overall, gender and age group stratified mean and standard error (SEM) values for 
physical activity and sedentary behavior outcome variables for the DPPOS cohort and the 
population weighted NHANES fasting subsample participants (≥40 years), indicate that males 
and females in the DPPOS were more sedentary and less likely to engage in light and total (light 
+ moderate-vigorous) physical activity when compared to similar age and gender individuals 
from the NHANES fasting subsample (table 7.11 for females and 7.12 for males). 
For both males and females the gap in mean values for sedentary behavior, light intensity, 
and total physical activity was widest in the youngest age group, where the DPPOS participants 
averaged greater than an hour more sedentary time per day (551.02 vs. 479.33 minutes/day in 
females and 551.56 vs. 481.12 minutes/day in males) and greater than an hour less light intensity 
physical activity per day (292.23 vs. 356.56 minutes/day in females and 290.28 vs. 358.64 
minutes/day in males) when compared to the population weighted NHANES fasting subsample. 
Although statistical comparisons could not be performed between the estimates for NHANES 
and the DPPOS cohorts (due to differences in sampling design and violations of normality and 
equal variance), the size of the standard errors for all estimates are very small (< 10 minutes) 
compared to the differences in time spent in sedentary behavior, light intensity and total physical 
activity. This suggests that these differences are likely to be statistically significant. 
However, estimates of moderate-vigorous physical activity were more similar between 
the DPPOS cohort and the population representative sample from the 2003-06 combined 
NHANES fasting subsample with some age/gender groups within the DPPOS reporting higher 
point estimates of moderate-vigorous physical activity than the comparable age/gender group 
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from the population weighted 2003-06 combined NHANES fasting subsample. Specifically, 
females aged 60-69 years and ≥70 years of age had slightly higher estimates of mean (SEM) 
minutes/day of MVPA when compared to weighted values for NHANES females in the same age 
group (13.31 SEM 1.01 vs. 11.75 SEM 0.86 and 7.46 SEM 0.83   vs . 6.52 SEM 0.81, 
respectively) and males aged 60-69 years and ≥70 years of age had slightly higher point 
estimates of mean minutes/day of MVPA when compared to NHANES males in the same age 
group (21.27 SEM 1.45 vs. 18.74 SEM 1.29 and 13.33 SEM 1.43 vs. 10.71 SEM 1.51, 
respectively). However, it is not known if these differences could be statistically significant. 
 
 
Table 7.11 Mean values for sedentary behavior and physical activity-related variables for female 
participants from the DPPOS and the NHANES 2003-06 fasting subsample (≥40 years of age) by age group 
 
 39-59 years 60-69 years ≥ 70 years 
DPPOS 
N= 466 
NHANES 
2003-06 
N= 424* 
DPPOS 
N= 402 
NHANES
2003-06 
N= 241* 
DPPOS 
N= 256 
NHANES
2003-06 
N= 251* 
Sedentary 
 (min/day  0-99 ct) 
 
551.02 
(3.82) 
479.33 
(6.80) 
546.58 
(4.05) 
506.62 
(12.72) 
569.00 
(5.51) 
550.52 
(6.53) 
Light PA (min/day 100-
1951 ct) 
292.23 
(3.74) 
356.56 
(4.81) 
277.72 
(4.12) 
334.60 
(7.39) 
244.97 
(4.81) 
270.50 
(6.22) 
Moderate-vigorous (MV) 
PA (min/day >=1952 ct) 
16.14 
(0.75) 
20.70  
(1.07) 
13.31 
(1.01) 
11.75 
(0.86) 
7.46 
(0.83) 
6.52 
(0.81) 
Total PA (Light + MVPA) 
308.37 
(3.95) 
377.26 
(5.04) 
291.03 
(3.96) 
346.34 
(7.59) 
252.43 
(5.04) 
277.02 
(6.47) 
Estimated Wear time 
(min/day) 
859.40 
(3.71) 
856.59 
(4.18) 
837.61 
(4.39) 
852.97 
(10.77) 
821.43 
(4.97) 
827.54 
(7.10) 
PA= Physical activity , * Population size prior to weighting 
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Table 7.12 Mean values for sedentary behavior and physical activity-related variables for male 
participants from the DPPOS and the NHANES 2003-06 fasting subsample (≥40 years of age) by age group 
 
 39-59 years 60-69 years ≥ 70 years 
DPPOS 
N= 103 
NHANES 
2003-06 
N= 432* 
DPPOS 
N= 204 
NHANES
2003-06 
N= 224* 
DPPOS 
N= 178 
NHANES
2003-06 
N= 294* 
Sedentary 
 (min/day  0-99 ct) 
 
551.56 
(11.17) 
481.12 
(5.56) 
559.68 
(6.30) 
535.21 
(11.42) 
572.43 
(6.50) 
590.86 
(8.81) 
Light PA (min/day 100-
1951 ct) 
290.28 
(9.61) 
358.64 
(5.24) 
264.41 
(5.65) 
309.36 
(5.28) 
227.20 
(5.85) 
254.29 
(5.57) 
Moderate-vigorous (MV) 
PA (min/day >=1952 ct) 
30.83 
(2.33) 
34.16  
(1.35) 
21.27 
(1.45) 
18.74 
(1.29) 
13.33 
(1.43) 
10.71 
(1.51) 
Total PA (Light + MVPA) 
321.11 
(10.56) 
392.79 
(5.84) 
285.68 
(6.12) 
328.10 
(5.83) 
240.53 
(6.31) 
265.00 
(6.07) 
Estimated Wear time 
(min/day) 
872.68 
(8.54) 
873.92 
(3.59) 
845.36 
(6.09) 
863.31 
(10.56) 
812.96 
(5.97) 
855.86 
(8.75) 
PA= Physical activity, * Population size prior to weighting  
 
7.6.3 Descriptive comparisons of DPPOS and NHANES physical activity and sedentary 
behavior levels stratified by age, gender, and diabetes status 
Based on the decision to include both the fasting subsample and the OGTT subsample in 
the comparisons with the DPPOS cohort, the primary comparisons between the DPPOS cohort 
and the larger fasting subsample from NHANES 2003-06 are presented first in figures 7.3 
(moderate-vigorous intensity physical activity), 7.4 ( light intensity physical activity), and 7.5 
(sedentary behavior). The comparisons between the DPPOS cohort and the OGTT subsample 
from 2005-06 are presented afterward, in figures 7.6 ( moderate-vigorous intensity physical 
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activity) , 7 .7 (light intensity physical activity), and 7.8 ( sedentary behavior), to support the 
result of the primary comparison. For the OGTT subsample, some categories were represented by 
less than 15 individuals and were not reported in figures 7.6-7.8 due to concerns over the 
possible loss of population representativeness (all values are presented in appendix A). 
Additionally, tests of trend could not be provided for the OGTT subsample due to small sample 
size. 
7.6.3.1 Comparisons for different intensities of physical activity 
Figure 7.3 illustrates the differences between mean minutes/day of moderate-vigorous 
physical activity (MVPA) for the DPPOS cohort and individuals from the combined NHANES 
2003-04 and 2005-06 fasting subsample. For the NHANES fasting subsample, although point 
estimates of MVPA were generally lower in individuals with diabetes and higher in normal 
glucose tolerant individuals, these trends were only significant in the youngest age groups of 
males (p<0.004) and females (p<0.03). 
Point estimates for mean minutes/day spent in MVPA where higher for males in all age 
groups from the DPPOS cohort when compared to individuals with diabetes or impaired glucose 
tolerance in NHANES (30.83 vs. 23.99 & 28.54, 21.27 vs. 11.51 & 20.22, and 13.33 vs. 9.13 & 
9.78, for the 39-59, 60-69, and ≥ 70 year age groups, respectively).  
Additionally, DPPOS males aged 60-69 and ≥ 70 years had slightly higher point 
estimates for mean MVPA than similar aged normal glucose tolerant males from the NHANES 
fasting subsample (21.27 vs. 19.40 minutes/day and 13.33  vs. 13.03 minutes/day).   
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 ≥ 70 years 
  ≥ 70 years 
  
  A.  Males; DPPOS & NHANES 2003-06 fasting subsample 
 
 
 
 
 
 
 
 
 
   
 
  
 B.  Females; DPPOS & NHANES 2003-06 fasting subsample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3 Mean minutes/day spent in moderate-vigorous activity by gender and age group for adults age ≥ 
39 years (≥40 years for NHANES) with ≥ 4 valid days of monitoring. For the classification of diabetes status 
(NHANES participants), the fasting plasma glucose test was used. Wald f-statistic p-values were used for p-
trend. 
   
 98 
Females in all three age categories of the DPPOS cohort had higher point estimates for 
mean recorded MVPA when compared to similar aged females in the NHANES fasting 
subsample with diabetes (16.14 vs. 10.88, 13.31 vs . 5.99, a nd 7.46 vs . 4.64 m inutes/day, 
respectively). Additionally, 60-69 year old DPPOS females had higher point estimates for 
reported MVPA when compared to females of similar age with impaired glucose tolerance from 
the fasting subsample (13.31 vs. 10.18  minutes/day). 
DPPOS females age ≥ 70 years had similar point estimate for mean daily MVPA when 
compared to the females age ≥ 70 years with normal glucose tolerance from the NHANES 
fasting subsample (7.46 vs. 6.35 minutes/day). However, this finding was not confirmed by the 
OGTT subsample point estimate for the mean daily MVPA in females aged ≥ 70 years with 
normal glucose tolerance (10.19 minutes/day).  
Figure 7.4 presents a comparison of time spent in light intensity physical activity (LPA) 
between the DPPOS participants and the NHANES fasting participants. All NHANES 
participants are presented by diabetes status group. For NHANES fasting males aged 40-59 and 
60-69 years there were significant trends in mean LPA with lower recorded LPA among 
individuals with diabetes and higher recorded LPA among normal glucose tolerant individuals 
(p<0.02 and p<0.01, respectively).  
A weak, non-significant trend, in the same direction, was seen in NHANES fasting 
males, aged ≥ 70 years (p=0.44).  Although, point estimates for mean daily LPA tended to be 
lower in individuals with diabetes than individuals without diabetes for all age groups of 
NHANES fasting females, the trend in LPA across all three diabetes status group was only 
statistically significant in females aged 60-69 years (p<0.03).   
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≥ 70 years 
≥ 70 years 
 
 
A. Males; DPPOS & NHANES 2003-06 fasting subsample 
 
 
 
 
 
 
 
 
 
 
B. Females; DPPOS & NHANES 2003-06 fasting subsample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.4 Mean minutes/day spent in light intensity physical activity by gender and age group for adults age 
≥ 39 years (≥40 years for NHANES) with ≥ 4 valid days of monitoring. For the classification of diabetes status 
(NHANES participants), the fasting plasma glucose test was used. Wald f-statistic p-values were used for p-
trend. 
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In general, daily averages of recorded LPA among DPPOS participants was lower than 
LPA among NHANES fasting sample participants with normal glucose tolerance or impaired 
glucose tolerance within the same age/gender group. Additionally, younger males and females  
(≤ 59 years of age) and older males (≥ 70 years of age) in the DPPOS had lower point estimates 
for mean minutes/day of LPA when compared to NHANES fasting sample participants in the 
same age/gender group.  
However, point estimates for mean daily LPA in females aged 60-69 years were similar 
between the DPPOS and the NHANES fasting sample (277.72 vs. 280.14) and point estimates 
for daily mean LPA for 60-69 year old males and females ≥70 years of age were slightly higher 
in the DPPOS cohort compared to the individuals with diabetes in the NHANES fasting 
subsample (264.41 vs. 255.74 a nd 244.97 vs . 233.24, r espectively). The trends in LPA across 
diabetes status groups was similar between the fasting subsample and the OGTT subsample and 
the levels of LPA were generally lower compared to the NHANES participants regardless of 
which measure of diabetes status was used. 
7.6.3.2 Comparisons for sedentary behavior 
 
Figure 7.5 presents a graphical comparison of time spent sedentary in minutes/day 
between the DPPOS cohort and individuals from the NHANES 2003-04 and 2005-06 fasting 
subsample. All comparisons are presented by gender and age groups. For NHANES fasting 
males aged 40-59 and 60-69 years there were significant trends in mean sedentary time 
(controlling for wear time) with higher recorded sedentary time among individuals with diabetes 
and lower recorded sedentary time among normal glucose tolerant individuals (p<0.02 and 
101 
p<0.03, respectively). The same trend was seen in NHANES fasting males, age ≥ 70 years, but 
was only borderline significant (p=0.06).  A lthough point estimates for mean daily sedentary 
time were higher in individuals with diabetes than individuals without diabetes, for all age 
groups of females in the NHANES fasting subsample, the trends in sedentary time (controlling 
for wear time) across all three diabetes status group were not statistically significant.   
Individuals in the DPPOS cohort spent more time, on a verage, in recorded sedentary 
behavior than individuals with normal glucose tolerance or individuals with impaired glucose 
tolerance in the same age/gender category from the NHANES fasting subsample (except for 
males aged ≥ 70 years).  
Based on point estimates, DPPOS participants aged 39-59 years also typically spent more 
time, on average, in recorded sedentary behavior when compared to individuals with diabetes in 
NHANES (551.56 vs. 491.28 minutes/day in males, and 551.02 vs. 509.79 minutes/day in 
females).  These findings are generally supported by the results from the OGTT subsample 
(figure 7.8). 
The mean amount of recorded time spent sedentary was similar between 60-69 year old 
males from the DPPOS cohort and the NHANES fasting subsample.  However, point estimates 
for time spent sedentary were lower for DPPOS participants, who were 60-69 year old females or 
were males ≥ 70 years old, when compared to similar gender/age individuals from NHANES 
(547.43 vs. 641.90, 546.58 vs . 579.98 m inutes/day, respectively). Also, based on the OGTT 
subsample results females ≥ 70 years of age in the DPPOS cohort spent less time in sedentary 
behavior per day, on a verage, than similarly aged females in NHANES with diabetes (figure 
7.6).  
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≥ 70 years 
≥ 70 years 
A. Males; DPPOS & NHANES 2003-06 fasting subsample 
 B. Females; DPPOS & NHANES 2003-06 fasting subsample 
* model includes wear time as a covariate
Figure 7.5 Mean minutes/day spent in sedentary behaviors by gender and age group for adults age ≥ 39 years 
(≥40 years for NHANES) with ≥ 4 valid days of monitoring.  For the classification of diabetes status 
(NHANES participants), the fasting plasma glucose test was used. Wald f-statistic p-values were used for p-
trend. 
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7.6.3.3 OGTT subsample comparisons 
The resulting values for time spent in different intensities of physical activity and 
sedentary behavior from the OGTT subsample support the relationships seen between different 
diabetes status groups within the NHANES fasting subsample and the DPPOS cohort. This is 
despite the fact that there are differences in specific values of physical activity and sedentary 
behavior between the OGTT subsample and the fasting subsample. For the DPPOS cohort and 
the NHANES fasting and OGTT subsamples, all values for time spent in moderate-vigorous 
intensity and light intensity physical activity, sedentary behavior, and other activity-related 
outcome variables are presented in appendices tables A.1 (males) and A.2 (females). The 
following section contains figures illustrating the means and standard errors for time spent in 
moderate-vigorous intensity physical activity (7.6), light intensity physical activity (7.7), and 
sedentary behavior (7.8) for the DPPOS cohort and the NHANES 2005-06 OGTT subsample. 
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≥ 70 years 
≥ 70 years 
 
  
  A.  Males; DPPOS & NHANES 2005-06 OGTT subsample 
 
 
 
 
 
 
 
 
 
   
 
  
 B.  Females; DPPOS & NHANES 2005-06 OGTT subsample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.6 Mean minutes/day spent in moderate-vigorous activity by gender and age group for adults age ≥ 
39 years (≥40 years for NHANES) with ≥ 4 valid days of monitoring. For the classification of diabetes status 
(NHANES participants), the oral glucose tolerance test was used. Wald f-statistic p-values were used for p-
trend. 
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≥ 70 years 
≥ 70 years 
 
 
    A.Males; DPPOS & NHANES 2005-06  OGTT subsample 
 
 
 
 
 
 
 
 
 
 
     B.Females; DPPOS & NHANES 2005-06 OGTT subsample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.7 Mean minutes/day spent in light intensity physical activity  by gender and age group for adults age 
≥ 39 years (≥40 years for NHANES) with ≥ 4 valid days of monitoring. For the classification of diabetes status 
(NHANES participants), the oral glucose tolerance test was used. Wald f-statistic p-values were used for p-
trend. 
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  ≥ 70 years 
  ≥ 70 years 
      
      
   A.Males; DPPOS & NHANES 2005-06 OGTT subsample 
 
 
 
 
 
 
 
   
 
 
 
   B. Females; DPPOS & NHANES 2005-06 OGTT subsample 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 * model includes wear time as a covariate  
 
 
Figure 7.8 Mean minutes/day spent in sedentary behaviors by gender and age group for adults age ≥ 39 years 
(≥40 years for NHANES) with ≥ 4 valid days of monitoring. For the classification of diabetes status (NHANES 
participants), the oral glucose tolerance test was used. Wald f-statistic p-values were used for p-trend. 
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7.6.3.4 Summary 
Not all trends in time spent sedentary and in different intensities of physical activity were 
significant across the diabetes status groups in the weighted NHANES subsample. However, for 
most age/gender groups there was the general appearance of a trend with higher mean minutes 
per day of sedentary behavior and lower mean minutes per day of physical activity among 
NHANES participants with diabetes. 
For male participants specifically, levels of moderate-vigorous physical activity (MVPA), 
appeared to be higher in DPPOS participants of all age groups, when compared to similar aged 
NHANES males with diabetes or impaired glucose tolerance. Additionally, the mean estimates 
of MVPA in minutes per day for DPPOS males in the 60-69 and ≥ 70 year age categories were 
similar, although slightly higher, than the mean MVPA estimates for normal glucose tolerant 
males in the same age category (based on the fasting subsample).   
For females, estimates of MVPA in minutes/day were higher in the DPPOS cohort for all 
age groups when compared to similar aged individuals in NHANES with diabetes, and when 
compared to individuals in NHANES with impaired glucose tolerance in the 60-69 year old age 
category, only. As expected, DPPOS females still appeared to spend less time in MVPA than 
normal glucose tolerant individuals in the weighted NHANES subsample.    
When compared to similar aged NHANES participants with diabetes, the DPPOS 
participants < 60 years of age, spent nearly an hour more per day in sedentary behaviors (for both 
males and females). However, in the older age groups the mean minutes per day of recorded 
sedentary time was more similar between the NHANES participants with diabetes and the 
DPPOS participants for males and slightly lower for DPPOS females in the 60-69 year old group 
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(and possible the ≥ 70 year old age group based on the OGTT subsample) when compared to 
similar age/gender NHANES participants with diabetes. 
7.6.4 Discussion 
The DPPOS participants had higher than expected levels of moderate-vigorous physical 
activity (MVPA) when compared to similar individuals in the population representative 
NHANES fasting and OGTT subsamples. During the initial Diabetes Prevention Program (DPP) 
intervention, participants were encouraged to meet a physical activity goal of achieving 150 
minutes/week of MVPA.16 In order to achieve this goal, participants were asked to become 
aware of the time they spent in MVPA and to adopt behavioral changes that would lead to an 
increase in physical activity at this intensity level, specifically.248 The DPP lifestyle intervention 
was shown to be successful in the lifestyle participants16 and was eventually given to all DPP 
participants prior to the start of the DPPOS.241 Therefore, finding higher than expected levels of 
MVPA in the DPPOS cohort is plausible and may reflect the effects of a successful lifestyle 
intervention on MVPA. 
Although, encouragement to reduce sedentary behavior, such as the amount of time spent 
watching television, was included briefly in session 4 of the intervention there were no explicit 
goals to reduce sedentary behavior or to increase light intensity physical activity (LPA). 
Therefore, it is reasonable to assume that the DPPOS participants would have similar levels of 
sedentary and light behavior as individuals in NHANES that are similar and age, gender, and 
diabetes status (impaired glucose tolerance and diabetes). These results suggest that, in general, 
the DPPOS participants spent as much, if not more, time in sedentary behavior and less time in 
LPA than individuals in NHANES with impaired glucose tolerance or diabetes. More 
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specifically for individuals < 60 years of age the DPPOS participants spent more time sedentary 
and less time in LPA than similar age/gender individuals in NHANES and for individuals ≥ 60 
years of age the values for time spent in sedentary behavior and LPA were more similar between 
the DPPOS participants and the NHANES participants with diabetes. This suggests that a more 
concerted effort should be placed on reducing sedentary behavior in lifestyle interventions. 
The weighted NHANES subpopulation used in this comparison provides a large U.S. 
population representative sample of individuals with which to compare the DPPOS cohort. Both 
studies utilized comparable, objective measures of physical activity and sedentary behavior. 
Unfortunately, race/ethnicity could not be accounted for, despite the fact that this variable 
appeared to have an effect on estimates of physical activity and sedentary behavior. However, 
the more influential covariates of age and gender were accounted for in the analysis design. 
Additionally, because the analysis of the NHANES study data requires incorporating the 
complex survey design elements (weights, strata, and clusters), only descriptive comparisons 
could be made between the NHANES study population and the DPPOS cohort. However, in this 
case the inability to present statistical comparisons for the results did not obscure the overall 
conclusions that the DPPOS participants spent more time, on average, in MVPA than expected, 
but not more time in light intensity physical activity or less time in sedentary behavior than 
expected, based on comparisons to a nationally representative sample. 
Overall, these results provide valuable contributions to the existing body of literature 
regarding the relationship between the development of diabetes and time spent in sedentary 
behaviors and in different intensities of physical activity. First of all, this work provides evidence 
for the cross-sectional relationship between glucose tolerance and time spent in LPA and 
sedentary behavior, in addition to time spent in MVPA. However, because the results are not 
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longitudinal, it is not clear whether low physical activity levels and high sedentary behavior lead 
to higher blood glucose levels or if individuals perform less physical activity and more sedentary 
behaviors as a result of higher blood glucose levels. This effort also provides evidence of a 
sustaining effect of the DPP lifestyle intervention program, on increasing time spent in MVPA 
among individuals at high risk for developing type 2 diabetes. However, these results also 
indicate that the DPPOS participants were at least as sedentary as the NHANES participants with 
diabetes. This would suggest that in future lifestyle interventions more effort needs to be placed 
on reducing sedentary behaviors in addition to the traditional focus on increasing MVPA. 
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8.0  DISSERTATION FINAL ASSESSMENT 
8.1 OVERALL CONCLUSIONS 
The high physical and economic burden of type 2 diabetes mellitus is an important public 
health concern.4 A better understanding of important modifiable risk factors for impaired glucose 
metabolism and type 2 diabetes, such as physical inactivity, is still needed. Additionally, there 
are few estimates of physical activity and sedentary behavior in the current literature that are 
based on objectively measured data for populations with impaired glucose metabolism or type 2 
diabetes. Furthermore, few studies have assessed whether methods used to measure physical 
activity and sedentary behavior, previously validated in the general population, are valid in 
populations with impaired glucose metabolism and type 2 diabetes mellitus.181,182 
Prior to the larger research effort that involved this dissertation work, there were no 
published studies reporting accelerometer measured time spent in different intensities of physical 
activity or sedentary behavior for adults or children and adolescents with impaired glucose 
tolerance or type 2 diabetes. The results of this work (and the larger research project including 
Kriska et al. 2013)233 add to the previous body of literature by i ndicating that in addition to 
differences between diabetes status groups in moderate-vigorous physical activity, individuals 
with diabetes appear to be more sedentary than similar age and gender individuals with normal 
glucose tolerance. This was true for the TODAY youth 233 and the DPPOS and NHANES adults 
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populations (≥ 40 years of age).  Additionally, these results suggest that, for all examined 
subgroups of the Diabetes Prevention Program Outcome Study (DPPOS) participants, there were 
higher than expected levels of moderate-vigorous physical activity, indicating that the lifestyle 
intervention used in the DPP may have a lasting effect on increasing levels of moderate-vigorous 
physical activity. However, levels of light intensity physical activity and sedentary behavior were 
similar to individuals with impaired glucose tolerance or type 2 di abetes, in a nationally 
representative sample of similar aged adults which was to be expected.  
Overall, the results of this effort support the idea that measurement methods capable of 
reporting accurate and reliable estimates of time spent in all intensities of physical activity and 
sedentary behavior are needed to further the understanding of how physical activity and 
inactivity relate to diabetes development. In relation to this, the results for the TODAY trial 
youth suggest that the 3 day physical activity recall (3DPAR) questionnaire may not be valid for 
measuring the quantity of time spent in physical activity or sedentary behavior in 
overweight/obese youth with type 2 diabetes. This is despite the fact that the 3DPAR has been 
previously validated as a measure of physical activity in the general youth population.235,249 
The results of unpublished analytical procedures from the TODAY trial project indicated 
that small changes in the processing algorithms, related to the definition of non-wear, could 
impact the results of estimated time spent in physical activity and sedentary behavior. Therefore, 
prior to reporting physical activity and sedentary behavior levels for adults in the DPPOS cohort 
an examination of the impact of small changes to the definition on non-wear in the accelerometer 
processing algorithms for a population representative sample of adults from the National Health 
and Nutrition Examination Survey (NHANES) . The results of these analyses indicated that 
changing the parameters for movement allowances during monitor recorded non-wear time 
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resulted in clinically significant differences in estimates of time spent sedentary, especially in 
older adults (aged ≥ 65 years). Therefore, suggesting that there is a need to better understand 
how accelerometer processing methods can impact on estimates of sedentary behavior, 
specifically. These results also suggest that there is a need for greater standardization across 
studies in the non-wear algorithms used in accelerometer processing for studies reporting 
sedentary behavior. 
8.2 PUBLIC HEALTH SIGNIFICANCE 
Without increased prevention and intervention efforts the rates of diabetes among adults 
in the United States is expected to rise to over 30% by 2050, primarily due to increases in type 2 
diabetes.8 In relation to this, a current goal for health people 2020 is to “reduce the disease and 
economic burden of diabetes mellitus and improve the quality of life for all persons who have, or 
are at risk for diabetes mellitus”.250 A physically inactive lifestyle and overweight/obesity are 
considered to be the most modifiable risk factors for type 2 diabetes and therefore, these risk 
factors are the target of most prevention and intervention efforts.15 
Based on the existing body of literature, it is possible that all levels of physical activity 
(light, moderate, and vigorous intensity) may help to reduce incident type 2 diabetes.214,223 There 
is now evidence that reducing the amount of time spent in sedentary behavior may provide an 
added benefit to the effects of moderate-vigorous physical activity on diabetes development.40,41  
These findings are particularly important due to the fact that populations are becoming 
increasingly sedentary as people are spending more time per day in activities that require low 
energy expenditure.52-54 It is therefore likely that future intervention efforts will include specific 
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guidelines aimed at increasing time spent in all intensities of physical activity and reducing time 
spent in sedentary behavior. As a r esult, there is a need for assessment of physical activity in 
populations with impaired glucose tolerance and type 2 diabetes that can capture all intensity 
levels of activity and sedentary behavior. 
This current effort helps to advance the understanding of physical activity and sedentary 
behavior assessment methods in populations with impaired glucose tolerance and type 2 diabetes 
and provides estimates for the average amount of time individuals in these populations spend in 
different intensities of physical activity and sedentary behavior. Additionally, this effort provides 
an examination of the differences in the amount of time spent in physical activity and sedentary 
behavior between individuals with normal glucose metabolism and individuals with impaired 
glucose metabolism. 
8.3 FUTURE DIRECTIONS 
The results of the dissertation have increased the understanding of time spent in physical 
activity and sedentary behavior among individuals with impaired glucose tolerance and type 2 
diabetes. Additionally, these results have confirmed the need to specifically validate physical 
activity measurement methods for use in collecting data on time spent in sedentary behavior and 
to ensure that methods previously validated in the general population are also validated for use in 
populations with impaired glucose tolerance and type 2 diabetes. 
However, the results of this effort have generated new questions that warrant further 
investigation. First of all, these results suggest that additional effort should be put into 
identifying and/or generating valid subjective methods for measuring physical activity in 
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populations with impaired glucose tolerance or type 2 diabetes. In relation to this, as part of the 
DPPOS accelerometer study, the agreement between the modifiable activity questionnaire 
(MAQ) and the accelerometer output will be examined to determine the efficacy of the MAQ for 
assessing both physical activity and domain specific sedentary behavior in a population of 
individuals with impaired glucose tolerance or type 2 diabetes. 
Secondly, although the accelerometer has been determined to be the most valid and 
reliable method for measuring time spent in all intensities of physical activity and sedentary 
behavior, the results of this investigation suggest that a greater understanding is needed to 
determine how all aspects of accelerometer processing methods may affect estimates of time 
spent sedentary. Future efforts in this area of research should also lead to the development of 
algorithms for accelerometer processing that are valid in the general population, as well as,  in 
individuals that spend more time in sedentary behavior (such as individuals with diabetes).  
Also, future efforts to reduce the incidence of diabetes and its complications through 
lifestyle changes should increase the emphasis on reducing sedentary behaviors in traditional 
interventions that already focus on increasing MVPA. This will lead to more effective health 
outcomes for individuals who have developed or are at high risk for developing type 2 diabetes.  
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APPENDIX A 
MEAN VALUES FOR PHYSICAL ACTIVITY AND SEDENTARY BEHAVIOR 
RELATED VARIABLES BY AGE, GENDER, AND DIABETES STATUS 
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Table  8.1   Mean values for sedentary behavior, different intensities of physical activity, and wear 
time for male participants from the DPPOS, the NHANES 2003-06 fasting subsample (≥40 years of age), and 
the NHANES 2005-06 OGTT subsample (≥40 years of age) with ≥4 days of valid wear time.   
 
  DPPOS NHANES 2003-06 
  
Diabetes 
Impaired glucose 
tolerance 
Normal glucose 
tolerance 
ALL 
Fasting 
Sample 
OGTT 
Sample 
Fasting 
Sample 
OGTT 
Sample 
Fasting 
Sample 
OGTT 
Sample 
39-59 
years 
of age 
Sedentary 
(min/day  0-99 ct)  
 
551.56 
(11.17) 
491.28 
(12.01) 
519.48 
(29.65) 
498.15 
(9.10) 
485.79 
(35.15) 
464.87 
(10.00) 
485.84 
(12.16) 
Light PA (min/day 
100-1951 ct) 
290.28 
(9.61) 
344.50 
(13.35) 
283.39 
(26.11) 
341.11 
(8.50) 
354.85 
(14.54) 
375.05 
(7.01) 
365.72 
(8.03) 
Moderate-vigorous 
activity (min/day 
>=1952 ct) 
30.83 
(2.33) 
23.99 
(2.96) 
21.85 
(5.20) 
28.54 
(1.7) 
26.85 
(3.93) 
39.43 
(2.23) 
38.94 
(2.12) 
Total activity 
(Light + MVPA) 
321.11 
(10.56) 
368.49 
(15.26) 
305.23 
(27.31) 
369.64 
(9.19) 
381.70 
(13.71) 
414.48 
(8.30) 
404.65 
(9.02) 
Estimated Wear 
time (min/day) 
872.68 
(8.54) 
859.77 
(14.39) 
824.71 
(23.23) 
867.79 
(9.06) 
867.49 
(1.96) 
879.35 
(7.75) 
824.71 
(23.23) 
60-69 
years 
of age 
Sedentary 
(min/day  0-99 ct)  
 
559.68 
(6.30) 
552.53 
(19.02) 
453.33 
(36.75) 
532.14 
(15.75) 
548.44 
(30.01) 
539.41 
(23.57) 
473.59 
(18.78) 
Light PA (min/day 
100-1951 ct) 
264.41 
(5.65) 
255.74 
(14.86) 
345.12 
(32.79) 
312.56 
(9.29) 
299.79 
(22.34) 
329.76 
(13.68) 
350.79 
(16.87) 
Moderate-vigorous 
PA (min/day 
>=1952 ct) 
21.27 
(1.45) 
11.51 
(3.47) 
49.51 
(11.89) 
20.22 
(1.95) 
15.83 
(2.39) 
19.40 
(2.39) 
18.46 
(2.21) 
Total activity 
(Light + MVPA) 
285.68 
(6.12) 
267.25 
(17.46) 
394.63 
(39.78) 
332.78 
(9.87) 
315.61 
(23.25) 
349.16 
(13.66) 
369.25 
(17.27) 
Estimated Wear 
time (min/day) 
845.36 
(6.09) 
819.78 
(13.51) 
847.96 
(12.06) 
 
864.92 
(14.95) 
864.06 
(24.83) 
888.57 
(20.57) 
842.84 
(25.26) 
70+ 
years 
of age 
Sedentary 
(min/day  0-99 ct)  
 
572.43 
(6.50) 
641.90 
(33.97) 
606.29 
(31.20) 
585.45 
(12.22) 
573.10 
(17.65) 
575.20 
(12.54) 
577.53 
(19.56) 
Light PA  (min/day 
100-1951 ct) 
227.20 
(5.85) 
246.56 
(10.33) 
269.73 
(20.24) 
252.30 
(7.45) 
252.29 
(18.29) 
260.48 
(9.64) 
260.22 
(11.71) 
Moderate-vigorous 
PA (min/day 
>=1952 ct) 
13.33 
(1.43) 
9.13 
(2.73) 
9.77 
(2.34) 
9.78 
(1.32) 
6.36 
(2.05) 
13.03 
(2.87) 
17.10 
(6.29) 
Total activity 
(Light + MVPA) 
240.53 
(6.31) 
255.69 
(10.81) 
279.50 
(20.44) 
262.08 
(7.44) 
258.65 
(19.41) 
273.51 
(11.16) 
277.33 
(15.70) 
Estimated Wear 
time (min/day) 
812.96 
(5.97) 
897.60 
(31.92) 
885.79 
(40.69) 
 
847.53 
(12.06) 
831.75 
(11.60) 
848.72 
(8.77) 
854.86 
(17.37) 
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Table  8.2   Mean values for sedentary behavior, different intensities of physical activity, and wear 
time for female participants from the DPPOS, the NHANES 2003-06 fasting subsample (≥40 years of age), 
and the NHANES 2005-06 OGTT subsample (≥40 years of age) with ≥4 days of valid wear time.   
 
  DPPOS NHANES 2003-06 
 
Diabetes 
Impaired glucose 
tolerance 
Normal glucose 
tolerance 
ALL 
Fasting 
Sample 
OGTT 
Sample 
Fasting 
Sample 
OGTT 
Sample 
Fasting 
Sample 
OGTT 
Sample 
39-59 
years 
of 
age 
 
Sedentary 
 (min/day  0-99 ct) 
 
551.02 
(3.82) 
509.79 
(23.58) 
434.27 
(25.39) 
469.12 
(11.2) 
533.87 
(28.44) 
480.74 
(9.12) 
470.55 
(12.71) 
Light PA (min/day 
100-1951 ct) 
292.23 
(3.74) 
325.51 
(16.67) 
377.23 
(16.03) 
355.97 
(7.96) 
307.56 
(23.36) 
359.90 
(7.36) 
365.80 
(10.68) 
Moderate-vigorous 
PA (min/day 
>=1952 ct) 
16.14 
(0.75) 
10.88 
(2.25) 
10.04 
(1.82) 
18.41 
(1.91) 
15.96 
(2.26) 
22.87 
(1.56) 
22.06 
(2.32) 
Total PA (Light + 
MVPA) 
308.37 
(3.95) 
336.39 
(17.24) 
387.27 
(16.55) 
374.38 
(8.91) 
323.53 
(24.59) 
382.78 
(8.12) 
387.85 
(11.81) 
Estimated Wear 
time (min/day) 
859.40 
(3.71) 
846.18 
(14.54) 
821.545 
(20.29) 
843.50 
(8.79) 
857.40 
(18.85) 
863.52 
(6.40) 
858.41 
(7.86) 
60-69 
years 
of 
age 
Sedentary 
 (min/day  0-99 ct) 
 
546.58 
(4.05) 
579.98 
(33.78) 
498.03 
(23.20) 
486.33 
(12.63) 
469.88 
(18.00) 
491.26 
(11.17) 
498.03 
(23.20) 
Light PA (min/day 
100-1951 ct) 
277.72 
(4.12) 
280.14 
(21.33) 
329.73 
(17.54) 
333.23 
(10.58) 
390.17 
(24.06) 
350.82 
(9.29) 
300.71 
(38.20) 
Moderate-vigorous 
activity (min/day 
>=1952 ct) 
13.31 
(1.01) 
5.99 
(1.46) 
12.22 
(2.09) 
10.18 
(1.59) 
6.77 
(2.30) 
14.77 
(1.52) 
3.48 
(1.27) 
Total activity (Light 
+ MVPA) 
291.03 
(87.96) 
286.13 
(21.75) 
341.95 
(18.95) 
343.41 
(10.38) 
396.94 
(24.13) 
365.59 
(9.94) 
304.18 
(38.85) 
Estimated Wear 
time (min/day) 
837.61 
(4.39) 
866.11 
(33.08) 
839.98 
(19.89) 
829.74 
(9.69) 
866.82 
(21.45) 
856.85 
(10.79) 
1036.95 
(119.30) 
70+ 
years 
of 
age 
Sedentary 
 (min/day  0-99 ct) 
 
569.00 
(5.51) 
559.48 
(9.01) 
581.54 
(18.00) 
531.56 
(13.53) 
544.71 
(18.83) 
560.91 
(14.53) 
519.20 
(23.41) 
Light PA (min/day 
100-1951 ct) 
244.97 
(4.81) 
233.24 
(15.62) 
287.25 
(35.73) 
285.88 
(13.71) 
263.04 
(18.84) 
275.82 
(8.64) 
294.50 
(16.60) 
Moderate-vigorous 
PA (min/day 
>=1952 ct) 
7.46 
(0.83) 
4.64 
(0.56) 
4.75 
(1.32) 
7.68 
(1.97) 
6.32 
(2.36) 
6.35 
(1.19) 
10.19 
(3.26) 
Total activity (Light 
+ MVPA) 
252.43 
(5.04) 
237.88 
(15.90) 
292.00 
(36.71) 
293.56 
(14.71) 
269.36 
(20.92) 
282.17 
(8.84) 
304.70 
(17.48) 
Estimated Wear 
time (min/day) 
821.43 
(4.97) 
797.36 
(16.74) 
873.534 
(34.13) 
825.12 
(9.68) 
814.07 
(18.44) 
843.08 
(12.98) 
823.90 
(17.19) 
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Table 8.3 The following table lists various abbreviations and acronyms used throughout the 
dissertation. The page on which each one is first used is also given. 
 
Abbreviation Meaning Page 
3DPAR Three Day Physical Activity Recall Questionnaire 8 
A1C Hemoglobin A1c 16 
ACSM American College of Sports Medicine 42 
ADA American Diabetes Association 16 
BMI Body mass index 10 
BRFSS Behavioral Risk Factor Surveillance System 23 
CDC Centers for Disease Control 9 
CI Confidence interval 2 
CVD Cardiovascular disease 2 
DPP Diabetes Prevention Program 3 
DPPOS Diabetes Prevention Program Outcomes Study 10 
FPG Fasting plasma glucose 16 
GPS Global Positioning System 28 
LPA Light intensity physical activity 50 
LPL Lipoprotein Lipase 38 
MAQ Modifiable Activity Questionnaire 63 
MEC Mobile examination center 54 
METs Metabolic equivalent units 20 
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Table B.1 Cont. 
 
 
 
Abbreviation Meaning Page 
MV/ MVPA Moderate-vigorous intensity physical activity 50 
NCHS National Center for Health Statistics 9 
NCI National Cancer Institute 56 
NHANES National Health and Nutrition Examination Survey 8 
NPV Negative predictive value 85 
OGTT Oral glucose tolerance test 16 
PA physical activity 50 
PPS Probability proportional to measurement size 53 
PPV Positive predictive value 85 
PSUs Primary sampling units 53 
SEM Standard error of the mean 73 
SQRT Square root 75 
TODAY Treatment Options for Type 2 D iabetes in Adolescents and Youth 
study 
7 
TPA Total physical intensity (light + moderate-vigorous) 50 
WHO World Health Organization 1 
YBRFSS Youth Behavioral Risk Factor Surveillance System 23 
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